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Tregulatory cells, Treg cells: cells that have both CD4 and CD25 glucoproteins on their surface. 
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1. INTRODUCTION 
1.1 BACKGROUND
Western societies have been facing a progressive increase of adverse reactions to food during the 
last ten years (1). As many as 20-30% of the general population report adverse reactions to food 
items, although only 1-3% of the patients have medically verified food allergy (2). Food 
hypersensitivity is defined as “objective reproducible symptoms or signs, initiated by exposure to a 
defined stimulus at a dose tolerated by normal subjects” (3). The food items most frequently 
reported as cause of hypersensitivity reactions are cow’s milk, wheat, fruits, hen’s eggs, peanuts, 
fish, seafood, and food additives (4). In most of the patients the symptoms comply with those of the 
irritable bowel syndrome (IBS), with bloating, abdominal pain, irregular and incomplete defecation 
being the most prominent (5). In addition, symptoms from other organs such as fatigue and joint 
pain often co-exist (6).  
It is commonly assumed that psychological and environmental factors typical of modern lifestyle 
such as stress and anxiety, modern nutrition, less physical activity, and reduced exposure to 
microbes are causally related to these non-allergic, hypersensitivity reactions to food (7-9).
While dermatological, respiratory, and systemic manifestations of food allergy are well known, 
reactions manifesting themselves in the gastrointestinal (GI) tract are less well characterised and 
understood (2). The symptoms are often variable and unspecific, and partly therefore difficult to 
diagnose and treat (2). This adds to the relatively limited armamentarium of diagnostic tools 
available for objective assessment of the afflicted individuals (2). When the symptoms remain 
unexplained following an extensive medical work-up, we have named the condition subjective food 
hypersensitivity (5). 
11
1.2 HYPERSENSITIVITY REACTIONS  
1.2.1 Immunological mechanisms 
There are four types of hypersensitivity reactions, three occur within the humeral branch and are 
mediated by antibody or antigen-antibody reactions: IgE-mediated (Type I), antibody-mediated  
compliment activation (Type II), and immune complex-mediated (Type III). A fourth type depends 
of activated T-helper (Th) cells and T-cytotoxic (TC) cells within the cell-mediated branch (10),  
figure 1. Only type I and type IV reactions are supposed to be involved in food hypersensitivity 
(10). 
Figure 1. The differences in effectors molecules generated in the four types of hypersensitive reactions (10).
Type I reaction is an immediate, IgE-mediated reaction manifested within minutes or 2-4 hours 
after allergen exposure (10). During the sensitisation phase antigen presenting cells (APC), 
including B-cells and dendritic cells present the allergen peptide to T-helper 2 cells (Th2-cells), 
resulting in a bias toward a Th2 form of immune response with production of IL-4, IL-5, and IL-13 
cytokines. The activated Th2 cells induce B-lymphocytes to produce memory cells and plasma 
cells, the latter producing IgE antibodies. The IgE class of antibody binds with high affinity to Fc 
receptors (FcRI) on the surface of tissue mast cells and blood basophils. A later exposure to the 
allergen cross-links the membrane-bound  IgE causing activation of mast cells and basophiles with 
release of histamine, leukotriens, and other mediators including tumor necrosis factor-alpha (TNF-
) and secondary recruitment and activation of eosinophils and neutrophils (11). By releasing such 
mediators, mast cells are believed to regulate epithelial ion transport, vascular permeability, smooth 
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muscle contraction and peristalsis, fibrogenesis, and enteric nerve function. Moreover, mast cells 
contribute to the recruitment of inflammatory cells such as neutrophils and eosinophils and to 
oedema formation, typical feature of allergic inflammation (Figure 2). The clinical manifestations 
of type I reactions can range from acute life-threatening conditions, such as shock with generalised 
urticaria, laryngeal edema, lower-airway obstruction, and hypotension, to delayed localised 
reactions, such as hay fever and eczema. The term allergy has come to be used interchangeably 
with Type I hypersensitivity (10).  
      
   
Figure 2. General mechanisms underlying an immediate type I hypersensitivity reaction (10)
Delayed- or type IV hypersensitivity reaction involves the cell-mediated branch of the immune 
system and is activated by IgG, IgA, IgM and IgD antibodies. Antigen activation of sensitised Th1
cells induces release of various cytokines that cause macrophages to accumulate and become 
activated. The net effect of the macrophages is to release lytic enzymes that causing localised tissue 
damage (10). The presence of delayed patterns of food allergy is believed to be concealed in a 
variety of diagnoses such as migraine headaches, asthma, eczema, IBS, depression, chronic fatigue, 
fibromyalgia, panic disorder, and arthritis (12). 
It has been estimated that humans consume approximately 100 tons of food during a lifetime (13). 
The GI barrier is a non-specific defence system consisting of gastric acid, digestive enzymes, 
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mucus, and an intact epithelial layer forming tight junctions and peristaltic movements (10; 14). 
Despite the barrier, about 2% of ingested food antigens are absorbed through the mature gut, and 
are transported throughout the body in intact form that may result in immunological responses (15). 
However, the most common consequence of this exposure is the state of hypo-responsiveness or 
tolerance (16). Mechanisms leading to mucosal tolerance include induction of cell death or cell 
anergy (11; 16). No specific IgE is produced, and eosinophils and mast cells remain in a resting 
state. This results in a state of controlled inflammation that characterises the normal gut mucosa 
and bowel function (17) (Figure 3), in contrast to a food hypersensitivity reaction.  
  
  
  
Figure 3.  Mechanisms leading to mucosal tolerance or hypersensitivity to food antigens in the GI tract (17).
1.2.2 Hygiene hypothesis 
Atopy depends on a genetic predisposition for the development of immediate hypersensitivity 
reactions against common environmental antigens (atopic allergy), most commonly manifested as 
allergic rhinitis but also as bronchial asthma, atopic dermatitis, and food allergy (11). 
The “hygiene hypothesis” from 1989 reported an inverse relationship between family size and birth 
order and development of atopic disorders, and proposed that a lower incident of infection in early 
childhood or acquired prenatally could be cause of the rise in allergic disease (18). Subsequently, 
the concept was further evolved into a broader notion that declining microbial exposure is a major 
causative factor in the increasing incidence of atopy in recent years (18). Epidemiological, clinical 
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and animal studies suggest that broad exposure to a wealth of commensally, non-pathogenic 
microorganisms early in life are associated with protection, not only against IgE-mediated allergies, 
but possibly also against type-1 diabetes and inflammatory bowel disease (IBD) (18-20). 
One pathways for protective effect of microbial exposure against atopy may involve the bacterial 
flora of the gut (21; 22). Several authors have found that non-allergic children had a greater 
prevalence of Lactobacilli and Bifidobacteria in their gut compared with the flora of allergic 
children, indicating these lactic acid bacteria may help prime or maintain normal gut flora and 
preserve intestinal mucosal integrity (21; 22). As a consequence, effects of antibiotics, domestic 
cleaning and hygiene on the bacterial colonisation of the gut in early years of development, and 
subsequent allergy development are extensively debated (23-25). 
1.2.3 Food hypersensitivity  
Until the late 1990`s the classification of adverse reactions to food was divided into toxic and non-
toxic reactions, the first may be due to naturally occurring in food ingredients (e.g. histamine fish 
poisoning or alfatoxins in peanuts) or be added during food preparation (3). Non-toxic reactions 
were classified into food allergy (immune mediated) or food intolerance (non- immune mediated) 
reactions. However, in clinical practice it is often unclear whether the problem is allergy or 
intolerance due to the time between ingestion and symptoms, and insufficient diagnostic tools (3).  
In 2001 European Academy of Allergology and Clinical Immunology (EAACI) revised the 
classification, and the term food hypersensitivity is now covering all kinds of adverse reactions to 
foods (3). The nomenclature was updated in 2003 (26). The term food allergy should be used when 
immunological mechanisms have been demonstrated, which includes both IgE-mediated and non-
IgE mediated reactions. All other reactions, which have sometimes been referred to as food 
intolerance, should be termed non-allergic food hypersensitivity (26) (Figure 4). The main 
difference between food allergy and non-allergy food hypersensitivity is that food allergy is caused 
by a protein interacting with the immune system, and food hypersensitivity is caused by substances 
in foods other than proteins, with no involvement of the immune system (26).  
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Food hypersensitivity
Food allergy Non-allergicfood hypersensitivity
IgE- mediated Non- IgE- mediated
Figure 4. Nomenclature of food hypersensitivity (26) 
Allergic reactions are of considerable concern because of a rapidly increasing prevalence during the 
past few decades (27). The prevalence of food hypersensitivity is greatest in the first few years of 
life (27). Previous studies conducted in England and The Netherlands, France and Denmark show 
that 15% to 45 % of the general population claim adverse reactions to food (4; 28-30). 
Approximately 25% of the United States` population believes that they have an allergic reaction to 
foods (4). The actual incidence confirmed by history and challenges suggests a prevalence rate 
closer to 2-8% in young infants and less than 2% in adults (4). Different types of food 
hypersensitivity (31) are presented in Table 1.
Table 1. Presentation of different types of food hypersensitivity (31). 
Gastrointestinal Cutaneous Respiratory 
IgE- mediated  
food allergy 
Oral allergy syndrome 
Gastrointestinal anaphylaxis 
Urticaria 
Angioedema 
Red flushes 
Acute rhinoconjunctivitis 
Acute asthma 
Mixed IgE and and cell-
mediated 
Allergic eosinophilic esophagitis 
Allergic eosinophilic gastroenteritis Atopic dermatitis Asthma 
Non-IgE-mediated food 
allergy 
Food protein-induced proctocolittis 
Food protein-induced enterocolittis 
Contact dermatitis 
Dermatitis 
herpetiformis 
Food-induced pulmonary 
hemosiderosis  
(Heiner`s syndrome) 
Cell-mediated food 
hypersensitivity 
Food protein-induced enterophaty 
Coeliac disease 
Contact dermatitis 
Dermatitis 
herpetiformis 
Food-induced pulmonary 
hemosiderosis  
(Heiner`s syndrome) 
Non-allergic food                  Enzyme deficiency (lactose intolerance), infections (bacteria, virus and parasites), 
hypersensitivity       pharmacologic psychological factors (stress, anxiety, psychological disorders) and other
        factors (caffeine, alcohol and biogene amines)
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1.2.4 Food allergens  
Although the diversity of the human diet is enormous, relatively few foods account for the majority 
of food allergies (4). In general, the most common food allergens in children worldwide are in milk 
and hen`s egg, but regional dietary habits and methods of food preparation clearly play  a role in the 
prevalence of specific food allergies in various countries around the world (4; 32). For example, the 
consumption of peanuts in China and the United States is essentially the same, but there is virtually 
no peanut allergy in China (33). The Chinese eat predominantly boiled or fried peanuts, whereas 
the Americans eat almost exclusively dry-roasted peanuts, a process of which have been shown to 
increase the allergenicity of the peanut protein (34). Sesame allergy is frequent in Israel, probably 
because of early introduction to tahini, which is a sesame paste used in a variety of dishes (35). In 
Spain, the most frequent cause of food allergy is from a hidden allergen in Anisakis simplex larvae 
that infects fish or shellfish. This might be due to the habit of eating fresh raw anchovy marinated 
in vinegar (36). Another important dietary allergen is soy, the use which has spread in such a way 
that today it is almost impossible to make a diet without soy (36). The foods that most often cause 
allergy in adults are seafood and tree nuts as well as fruits and vegetables where the primary 
sensitisation mainly comes from pollen (36).  
Unlike plant food or pollen allergens, almost all the animal food allergens have homologs in the 
human proteome that may affect the way in which they are recognised by the human immune 
system (37). Jenkins et al. (37) have shown that proteins with   54% to human homology were all 
allergenic, whereas those with a sequence identity greater than 63% were rarely allergenic. The 
only exception is the cow`s milk allergen bovine serum albumin that is 76% identical to the human 
homolog. It is generally thought that this protein is a much less important cow`s milk allergen than, 
for example, the caseins (37). Newly, Commins et al. (38) suggested that IgE antibodies to 
carbohydrate epitopes can be an important factor in food allergy. They have shown that IgE 
antibodies to the carbohydrate galactose--1.3 (-gal) is associated with an unusual form of delayed 
anaphylaxis, which follows after eating meat like beef, pork or lamb, that carries -gal (38). These 
thoughts are different from established teaching on food allergy because this form develops in adult 
life, the reactions start 3 to 6 hours after eating the meat, and the patients generally have negative or 
weak responses to skin prick tests with meat extracts (38). 
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1.2.5 Diagnostic tests  
No single test is able to identify all patients with food allergy or indicate the severity of the diseases 
(39). The most common tests are a detailed medical history, skin prick test, total – and specific IgE, 
atopy patch test, elimination diet and oral food challenge, which can be performed as open, single-
blind or double-blind placebo-controlled food challenges (DBPCFC). For many years DBPCFC has 
been considered the “gold standard” for diagnosing food allergy (40). Some authors point out that 
the general lack of standardised methods for the oral challenges is a primary limitation of the 
DBPCFC (40). The procedure is also expensive, cumbersome and time-consuming. For research 
purposes, mediators that are released from mast cells and eosinophils (histamine, tryptase and 
eosinophil cationic protein) may be measured in serum, urine or stool (41-44).  
A study by Santos et al. (45) showed that intraluminal administration of food antigens in patients 
with “true” food allergy induced a rapid increase in intestinal release of tryptase, histamine, and 
prostaglandin D. The increased release of these mediators was associated with a notable water 
influx (45; 46) (Figure 5). The symptoms are usually acute, short lasting abdominal cramps and 
diarrhoea (45). A major problem is that all traces of an allergic reaction might have disappeared at 
the time of investigation (45).
Figure 5. Effect of antigen challenge on jejunal release of (A) tryptase, (B) histamine, (C) prostaglandin D
(PGD2), and (D) water flux in healthy volunteers and patients with food allergy  (46).
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Other provocation tests are gastroscopic provocation tests to challenge the gastric mucosa with food 
allergens during upper endoscopy,  or colonoscopic allergen provocation test where biopsies are 
taken from the provocation areas as well as from unprovoked caecal mucosa (42). Also, direct 
duodenal food provocation may be monitored by transabdominal ultrasonography, but further 
methodological validation is needed before its clinical utility can be determined (47).  
    
1.2.6 Management and prevention
The cornerstone of food allergy management is to vigilantly avoid trigger foods and maintain 
readiness to treat allergic reactions, for example with self-injectable epinephrine (48). Currently, 
numerous strategies for definitive treatment are being studied, including sublingual/oral 
immunotherapy, injection of anti-IgE antibodies, cytokine/anticytocine therapies, Chinese herbal 
therapies, and novel immunotherapies utilizing engineered proteins and strategic 
immunomodulators (49). However, most of the clinical studies concerning these new therapies are 
still performed in animal models, but they do offer hope for better treatments in humans in the near 
future (48-50). 
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1.3 IRRITABLE BOWEL SYNDROME 
Irritable bowel syndrome is one of the most common disorders encountered in modern medicine. It 
is a functional disorder of the lower GI tract whose clinical expression is characterised by 
abdominal pain and/or discomfort associated with bloating and disturbed bowel habits (51). The 
prevalence of IBS in western Europe and North America is estimated to be 5% - 25%, which 
accounts for about 20% - 50% of the referrals to gastroenterology clinics (52). In most studies, 
more females than males have IBS (52), and more than 60% of IBS patients report worsening of 
symptoms after meals (53).  
The etiology of IBS is complex and still unclear (52). Proposed mechanisms include visceral 
hypersensitivity, altered GI motility and fermentation,  post-infectious intestinal alterations, 
anxiety, depressions and diet (53; 54). The mechanisms behind the disturbances are thought to be a 
result of disturbed neural function along the brain-gut axis, a low-grade inflammation within the 
gut wall, and altered immunological function (55). Also, alterations in the gut flora, which can have 
an impact on the gut immune system and affect nerve function, has been a major focus of research 
in recent years (56-59) (Figure 6). 
Psychological Factors
Neurotransmitter imbalance?
Infection and inflammation?
Altered Motility
Distension
Visceral Hypersensitivity
Pain
Bloating
Urge to defecate
INTERACTION
INTERACTIONINTERACTION
Figure 6. Suggested pathophysiology of the Irritable Bowel Syndrome (57).
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In clinical research of IBS, most studies apply the definitions enshrined in the Rome II (60) or 
Rome III criteria (61), table 2.  
Table 2. Diagnostic criteria in ROME III (61). 
At least 3 days per month in the last 3 months with symptoms onset at least 6 months prior to diagnosis, associated with 
two or more of the following:  
• Relief with defecation, 
• Onset associated with change in frequency of stool    
• Onset associated with change in form of stool  
Symptoms that cumulatively lend support to the diagnosis of IBS: 
• Abnormal stool frequency (>3 bowel movements per day and <3 bowel movements per week) 
• Abnormal stool form (lumpy/hard or loose/watery) 
• Abnormal stool passage (straining, urgency, or feeling of incomplete evacuation) 
• Passage of mucus  
• Bloating or feeling of abnormal distension 
The process for developing these criteria started in 1989 in Rome with the Rome I Criteria for IBS 
established in 1992, the Rome II Criteria for IBS in1999, and to the recent Rome III Criteria in 
2006. Rome II and Rome III incorporated paediatric criteria to the consensus (61). The changes 
from Rome II to Rome III reflect mainly updates in the literature and committee recommendations 
derived from these new data (61). In addition, a few modifications in the categories and criteria 
were made. Symptoms are now recommended to originate 6 months before diagnosis and be 
currently active for 3 months (61). Furthermore, there have been some changes in classification  
different categories of functional gastrointestinal disorders (61).  
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1.4 LIFESTYLE 
Lifestyle can be understood in many different ways (62). In sociology, a lifestyle is the way a 
person or a group lives (62). This includes patterns of social relations, consumption, entertainment, 
and dress (62). Max Weber (63) distinguishes between two independent aspects of lifestyle; life 
conduct and life chances, and  emphasizes lifestyle as means to social differentiation, which can be 
used to acquire or maintain a certain social status. Lifestyle is based not so much on what a person 
produces but on what she or he consumes (63). Lifestyle of an individual is understood as relatively 
stable patterns of behaviour and habits typical for the groups the individual belongs to, or the 
groups she or he wants to belong to (64). 
Our lifestyle has changed markedly during the last two generations. Education patterns, gender 
roles and family structures, social patterns and habits, values and cultural status are very different 
compared with the lifestyle 30 years ago. The economy, especially in Western countries, allows 
young people to travel much more than their parents and grandparents, they spend far more time 
and money at restaurants, and they are less prone to physical activity, which all together affect 
health (64). 
During the last 20 years lifestyle surveys have focused on health behaviours and lifestyle changes 
that may improve health, such as smoking, alcohol consumption, dietary habits and physical 
activity (65).  
1.4.1 Diet 
The modern diet in most westernised countries differs considerably from that of previous 
generations, in which the prevalence of allergy was significantly lower (66). Nowadays, the diet is 
dominated by food that has been processed, modified, stored and transported long distances (66). 
This is in contrast to the traditional diet, which compromise food that was produced and marketed 
locally and was eaten shortly after harvesting (66). Changing diet, as an explanation of trends in 
atopic disorders, may not only have a microbial effect by altering the gut flora, but also have 
biological plausibility via the nutrients needed for healthy immune system development, such as 
polyunsaturated fatty acids (PUFA) and antioxidants (67).  
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A large change in the type of fat consumed have occurred in western populations with an increase 
in the intake of omega-6 family of PUFA, mainly as the plant-derived linoleic acid, and a decrease 
in omega-3 PUFA found in especially in fatty fish like salmon, herring, tuna and sardines, and fish 
oils (68). The long chain polyunsaturated fatty acid (LCPUFA), arachidonic acid (AA) (20:4 n-6) is 
the precursor for the synthesis of prostaglandin E2 (PGE2) and thromboxanes (via cyclooxygenase 
enzymes) and 4-series leucotienes (LTB4) (via 5-lipooxygenase enzymes), which are mediators of 
inflammation (68). In addition to pro-inflammatory effects, PGE2 exerts effect on the Th1/Th2 
balance, decreasing the production of the Th1-type cytokines interferon gamma (IFN-) and IL-2, 
and enhancing the production of Th2-type cytokines IL-4 and IL-5,  promotinging IgE syntesis by 
B cells and allergic reactions (69). Increasing consumption of omega-3 LCPUFA results in their 
incorporation into cell membranes. This incorporation occurs largely at the expense of AA, so 
decreasing the availability of the substrate for prostaglandin E2 formation. Thus, it has been 
proposed that omega-3 LCPUFA will be protective towards allergic disease (70). However, there is 
conflicting evidence on the use of omega-3 and omega-6 supplementation for prevention of allergic 
diseases (71).  
Probiotics are live microbial organisms that are administered in foods or supplements which in 
adequate doses confer a health benefit on the host (72). Recent studies have demonstrated reduction 
in abdominal pain and bloating when treating patients with specific species of Lactobacillus and 
Bifidobacteria (72; 73). However, the impact of probiotics in IBS remains unclear, and well 
designed studies paying attention to both clinical outcome and mechanistic aspects are required 
(73).  
A common dietary advice for patients with IBS, namely supplemental fibre, has come under fire 
(74). These carbohydrates are incompletely or not digested in the small intestine, but are partly or 
totally fermented in the large bowel (74). Recent studies indicate that such malabsorption of 
undigestible but fermentable carbohydrates may be poorly tolerated by patients with IBS and 
subjective food hypersensitivity (75). A recent study by Austin et al. (76) showed that a very low-
carbohydrate diet (20g/d) improved symptoms and increased quality of life (QoL) in patients with 
diarrhoea-predominant IBS. The typical American diet provides approximately 300g of 
carbohydrates a day. FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and 
polyols), a term introduced by Gibson and Shepherd (77), are short-chain carbohydrates and sugar 
alcohols (such as sorbitol and mannitol) widespread in the diet. These compounds have three 
common functional properties; they are poorly absorbed in the small intestine, are osmotically-
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active molecules, and are rapidly fermented by the bacteria in colon, inducing abdominal distension 
and discomfort in many people, especially those with IBS (77). Gibson and Shepherd showed that a 
low FODMAP diet provided good relief of symptoms in 75% of patients with functional GI 
disorders, but further studies are needed to clearly define FODMAD-rich and FODMAP-poor 
foods, and the cut-off levels of FODMAP contents, which dictates whether the diet is classified as 
high or low (77).  
Peppermint oil may be effective in IBS patients due to smooth muscle relaxing properties (78), but 
despite numerous reviews on this subject, it is very difficult to give general dietary advice (79). 
Foods undoubtedly precipitate symptoms in many patients with subjective food hypersensitivity 
and IBS; but the precise mode of action remains unclear and many vary from one individual to 
another, and there is doubt that diet can be used solely in the treatment of IBS (80). 
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1.4.2 Quality of life 
The term quality of life (QoL) is used in a wide range of contexts to evaluate the general well-being 
of individuals and societies (81). The World Health Organization Quality of Life Group, a 
worldwide research group organized by the World Health Organization, defines quality of life as 
individuals’ perceptions of their position in life in the context of culture and value systems in which 
they live, and in relation to their goals, expectations, standards, and concerns (82). The term health-
related QoL is often used to indicate QoL as it relates to diseases or treatments (83). Thus, QoL is a 
broad-ranging concept that incorporates individuals’ physical health, psychological state, social 
relationships, personal beliefs, and their relationship to salient features of the environment (84) 
(Figure 7).
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Figure 7. Conceptual model of risk factors and disease variables related to health-related QoL in functional 
gastrointestinal disorders (84). 
  
Research studies are beginning to identify some of the factors that influence QoL in IBS (85-87). 
What determines how much IBS affects QoL are the frequency and severity of symptoms, having 
other medical conditions along with IBS or presence of multiple non-GI physical symptoms, and 
depression (85-87). Patients with mild IBS may not have worse overall QoL than the general 
population (88).
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1.5 PSYCHOLOGICAL FACTORS 
1.5.1 Subjective health complaints 
Subjective health complaints (SHC) are referred to as “unexplained symptoms” or complaints 
without objective pathological findings (89). The main categories of SHC are musculoskeletal 
complaints, “pseudoneurological” complaints like fatigue, tiredness, dizziness, vertigo and 
headaches, and GI complaints like pain, bloating and diarrhoea (89). The complaints are normal 
everyday complaints, and most of us do not seek medical assistance for these conditions. However, 
health care consumption is significantly associated with SHC, and for some individuals they reach 
a threshold where sick leave is necessary (90). Medically unexplained symptoms are associated 
with high rates of disabilities, and the management of the symptoms is perceived as unsatisfactory 
from the perspective of both the patients and the physician (90). 
In our society, a variety of subjective illnesses with few or non objective findings have appeared 
under different labels for years (91). Examples are chronic fatigue syndrome, fibromyalgia, 
burnout, food hypersensitivity, chronic low back pain, and multiple chemical sensitivity (92). Paul 
Briquet`s work from 1859 was the first description of patients feeling that they had been sickly 
most of their life, and complained of multiple symptoms referable to numerous different organ 
systems (93). The patients were often fatigue, and they claimed pain in the chest, arms, and legs. In 
addition, GI symptoms were common, especially bloating and nausea (93). The etiologic factors 
were youth, female sex, family history of the disorder low social class, and poor physical health, 
which are the same as those identified to day for SHC (94).  
As many as 96% of the general Norwegian population and 75% of the Nordic European countries 
report some SHC during the last 30 days (95). The definition of subjective food hypersensitivity is 
analogous to the general definition of SHC, and consistent with recent recommendations where 
non-toxic adverse reactions to food are referred to as food hypersensitivity (3; 94). Without 
objective criteria for judgement, diagnostics become difficult and controversial (90). Nevertheless, 
the patients still have pain or discomfort and feel in need for help and treatment (90). In Norway, 
almost 50% of sick leave is based on subjective statements from the patients, with few or no 
objective findings (96). The majority of these complaints are related to muscle and joint pain, but 
GI problems are also very common (96). Eriksen and Ursin suggest that these complaints are based 
26
on sensations from what usually are normal physiological processes. Furthermore, they suggest that 
sensitization is the psychobiological mechanism explaining the individual differences in tolerance 
and acceptance of common health complaints (97). van den Bergh et al. (98) argue that medically 
unexplained symptoms and syndromes may promote two extreme positions. One is that some 
specific explanatory mechanisms of dysfunction in the body must exist that has yet to be 
discovered. The other assumes that such symptoms are mainly the result of perceptual-cognitive 
processes, strengthening bodily sensations resulting from stress and anxiety (98). Cognitive- 
emotional sensitisation is supposed to be common in medically unexplained somatic complaints, 
and may even play a role in the aetiology of the complaints  (94; 99).  
1.5.2 Sensitisation and somatisation 
Sensitisation is defined as increased reactivity to stimuli in pain pathways, and visceral 
hypersensitivity is the exaggerated experience of pain in response to mildly painful or even normal 
visceral stimuli (99). Generally, sensitisation is caused by an increased efficiency in the synapse 
due to repeated use, in particular following irregular and extreme stimulation (99; 100). 
Sensitisation constitutes a feed-forward mechanism, helping the individual to react more efficient in 
situations with increased probability of harm (99). Sensitised persons are continuously scanning the 
environment for offending agents. They are also constantly worried about their condition and doing 
their best to avoid situations to which they attribute their problems (101). Those who have an 
extreme concern may develop a cognitive bias for information related to somatic disease. They 
over-report the somatic sensations and misattribute or over-interpret ambiguous information in 
terms of their illness beliefs (99), and because emotional information often gets processing priority, 
it causes interference in the processing of other information (99).  
According to Brosschot (99), cognitive bias is a higher form of cognitive-emotional sensitisation, 
or simply cognitive sensitisation. Sensitisation, defined as an increased reactivity to stimuli, has 
been postulated as the underlying mechanism for somatisation disorders (99-101). Somatisation 
may be viewed as a psychological or behavioural trait, seen as the propensity to experience and 
report somatic symptoms, to misattribute them to disease, and to seek medical attention for them 
(99). Alexithymia, enhanced fantasy life and difficulties in differentiating one`s feelings and 
expressing them in words, have been associated with somatisation and depressive disorders (102-
104). 
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1.5.3 Stress   
The definition of stress has been source for discussion and disagreement among researches for 
years (105). The Cognitive Activation Theory of Stress (CATS) (106) views the stress as an alarm 
reaction operating whenever the organism registers that there is a discrepancy between what is 
expected and what really exists (106). According to CATS (106), physical demands and 
psychological characteristics that produce the stress response have nothing in common (107). All 
stimuli are filtered or evaluated by the brain before they gains access to the response system. The 
main ‘‘filters’’ are related to stimulus expectancy (what does the stimulus mean?) and to response 
outcome expectancy (what can I do about the stimulus?) (106). The stress response is a part of our 
biological inheritance, and it affects endocrine, vegetative, immune system, and biochemistry in the 
brain (106). The alarm, or stress response, depends on both the individuals` experience with the 
stressor, and the experiences of dealing with the stressor, in any particular situation (106). In other 
words, it is the individual’s experience of the demands and the expectancies of the outcome, which 
determine whether the stressor or the demands will cause stress responses. If sustained, they may 
cause illness and disease in man and animals (106) (Figure 8).  
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Figure 8. The main aspects of CATS. The load (1, stressor, stress stimuli) is evaluated by the brain (2) and may result 
in a stress response (3, alarm) that is fed back (4) to the brain. The physiological stress response may lead to training or 
straining, dependent on the type of activation. Phasic arousal is seen in individuals with a positive expectancy. 
Sustained arousal may lead to pathology (strain). The brain may alter the stimulus (5) or the perception of the stimulus, 
by acts or expectancies (106).
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Traditions for assessing the role of stress in disease risk are focusing on environmental events or 
experiences that are “objectively” associated with substantial adaptive demands and on individuals` 
“subjective” evaluation of their abilities to cope with the demands (108). The Karasek`s 
Demand/Control model is an “objective” model where a combination of high psychological 
demands and low task control and skills used at work may predict stress-related ill health 
behavioural (108). Whether a person’s job is perceived as stressful depends on work environment, 
social support, feeling of being in control of the situation, and coping mechanisms (105; 108).  
Previous studies have shown that job stress is often associated with heart disease, musculoskeletal 
pain and depression (108; 109). Jobs with high demands and low control carried the highest risk of 
illness and disease (110). Control refers to the possibility of using one’s own discretion and having 
authority on how to perform work (110). Low psychological demands and high levels of control 
carried the lowest risk of illness and disease. Jobs with high demands and high control, and 
opposite, with low demands and low control carried an average risk (110) (Figure 9). 
Figure 9. The Demand/Control model propose that job strain results from a combination of high psychological 
demands with little freedom to make decisions affecting work (e.g., low control). The resulting job strain increases the 
risk of disease. By contrast, if high demands are combined with high levels of involvement, the stress can be positive, 
stimulating active learning and personal development (110). 
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Tache et al. (111) suggest that all kinds of stress release corticotrophin releasing factor (CRF), 
which acts upon the central vagal motor nucleus to suppress efferent vagal activity. This activity 
evokes widespread autonomic changes, including depression of gastric motility and increased 
colonic transit time (111) (Figure 10), which means that both gastric emptying and the stomach’s 
ability to adapt to a new volume without an increase in pressure are impaired (111). Impairment of 
the reflex might be a reason why meal related epigastric discomfort is generated in patients with 
functional GI disorders (112). CRF receptors are found not only on neurons but also on different 
immune cells including macrophages, lymphocytes and mast cells. When activated, histamine and 
other mast cells-derived factors may cause vasodilatation in human skin (113). Recently, Alonso et 
al. (114) reported that chronic life stress may predispose to gut mucosal inflammation in healthy 
women. The abnormal epithelial response was characterized by an enhanced permeability to 
antigenic macromolecules. In susceptible individuals, excessive stress exposure is suggested to 
predispose these persons to develop a new disease or to exacerbate a previous existing one, which 
may be the case of IBS in women (114). 
   
Figure 10. Various stressors induce inhibition of gastric emptying and stimulation of colonic motor function (111) 
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1.5.4 Coping 
Coping has been defined as strategies (115) and strategy styles (116) used to handle perceived 
stress. The expectancy of coping success is believed to be the essence of coping (117).  According 
to expectancy theories, behaviour is a function of the expectancies one has and the value of the goal 
toward which one is working. Three main types of expectancies linked to outcome are described; 
outcome expectancies, role expectancies and control expectancies (118). Outcome expectancies are 
referred to as expectancies of improvement or expectancies of usefulness/helpfulness, and how 
strongly patients believe that therapy will help them get better (116). Role expectancies are defined 
as patterns of behaviour viewed as appropriate or expected of a person who occupies a particular 
position (119). Control expectancies are conceptually related to the locus of control concept. Locus 
of control refers to the belief that a consequence (e.g. getting better) either depends on one’s own 
efforts (internal locus of control) or is controlled by external factors such as fate (external locus of 
control) (120).  
 In the psychotherapy context, patients` engagement would be influenced by their control 
expectancies; positive outcome and efficacy expectancies would facilitate active participation, 
whereas negative expectancies would predict a rather passive role (116). From a theoretical point of 
view, patients who actively contribute to a therapeutic change are more likely to improve compared 
with patients who let the experts do (118) (Figure 11). Coping defined as "positive response 
outcome expectancies," focuses on the subjective experience of the "coping" person irrespective of 
situation or outcome, and is firmly based on the theory of activation in explaining the somatic 
reactions, and ultimately health consequences, to stress (106).  
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Figure 11. Process model of connections between expectancies, action and outcome (118). 
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1.5.5 Modern health worries 
Over recent years there has been a steady change in the publics` perception of the relation between 
aspect of modern life and health (121). Concerns about safety of mobile phones, air pollution, 
vaccines, food additives etc. have led to a heightened awareness of the effect of  environmental 
changes on health (121). Also, popular media now seem to focus more on health threats and 
highlights toxic and environmental causes of illness that may influence individuals` perceptions of 
vulnerability to many features of everyday life (122). Research has shown that patients who are 
most concerned about effects of modern life on health are also more likely to complain of somatic 
symptoms, have more functional illness, and consume more complementary health care than 
patients with fewer concerns about modernity (121). Filipkowski et al. (122) showed that modern 
health worries (MHW) were related to the number of SHC and visits to health care providers. 
Another study suggests that MHW are important psychological factors to consider with regards to 
attitudes toward functional foods (123). The study of MHW may thus be important for 
understanding aspects of functional disorders (122). 
1.5.6 Biopsychosocial Model
Disease is defined as “the verifiable evidence of a pathological state”, while illness is defined as 
“the patient’s perception of ill health, which is symptom reports, perceptions, and behavior” (124). 
For example, a clinical condition can range from disease without illness (hypertension or 
asymptomatic ulcer), to illness without disease (fatigue or chronic abdominal pain). In the 
biomedical model the latter has been labeled as “psychosomatic”, a term that question the reliability 
of the symptoms, even though they are very real to the patient (125).  
Thirty years ago Georg Engel (126) highlighted the inadequacies and limitations of the traditional 
biomedical model and encouraged the development of a biopsychosocial approach. This 
biopsychosocial approach posits that biological (diseases, genetic dispositions), psychological 
(thoughts, emotions, behaviour), and social (family, community) factors all play a significant role 
in human functioning in the context of disease or illness (126). The biopsychosocial model was 
suggested as a more complete conceptual framework to guide clinicians in their everyday work 
with patients. The study of every disease should include the associated psychosocial aspects, 
exemplified in the biopsychosocial model of IBS (125) (Figure 12).  
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Figure 12. Biopsychosocial Model of IBS. Early life factors influence later psychosocial factors, physiological 
functioning, their interaction via the CNS/ENS axis and susceptibility to developing IBS. The combined and integrated 
effects of altered physiology and the person's psychosocial status will affect how the symptom is experienced, the 
degree of symptom behaviour and ultimately the outcome (taking of medications, physician visits, daily functional 
status and quality of life). Furthermore, the clinical outcome will, in turn, affect the severity of the disorder (125).   
However, the usefullness of the biopsychosocial model has been questioned. Tavakoli thus (127) 
argues that the biopsychosocial model should be avoided because it promotes an artificial 
distinction between biology and psychology, and merely causes confusion in psychiatric 
assessments and training programs. McLaren (128) claims that the biopsychosocial model is neither 
a theory, nor a model but a “vague, ill-defined, well-meaning froth” masquerading the incomplete 
understanding of the problem. 
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1.5.7 Brain-gut axis 
The brain-gut axis can be defined as the bidirectional communication between the CNS and the 
enteric nervous system (ENS) (129). Also, afferent signals arising from the lumen of the gut are 
transmitted via various visceral afferent pathways (enteric, spinal and vagal) to the CNS. According 
to the brain-gut axis, the various aspects of IBS symptomatology may be viewed as dysregulation in 
the complex interplay between events occurring in the gut lumen, the mucosa, the ENS and the 
CNS leading to alterations in sensitisation, motility and immune function (129; 130). The existence 
of an extensive brain-immune network suggests that the immune system should be under at least 
partial influence by psychological processes including learning, psychological stress, emotions, and 
sensory processes (130). Recent studies also highlight the evidence that intestinal microbiota may 
be involved in neural development both centrally in the brain and peripherally in the ENS,  
modulating pain perception and even behaviour (56; 131). Changes in the microbiota, induced by 
infection or antibiotics, or other event such as stress, which are the strongest risk factors known for 
the development of IBS, may contribute to inflammation and GI pathology (56). It is possible that 
disruption or dysregulation of this homeostatic mechanism by stress or infection could affect 
susceptibility to psychiatric disorders, such as anxiety and depression (132). Taken together, 
although the psychoneuro-immunologic research over the last three decades has confirmed the 
existence of bi-directional interactions between the brain and the immune system, the critical 
question of whether behavioural manipulation, e.g. stressors or intervention, can affect immunity so 
as to influence health and survival, still remains to be answered (130). 
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2. AIMS OF THE PRESENT STUDY 
The overall objective of this study was to investigate patients with gastrointestinal complaints self-
attributed to food hypersensitivity (subjective food hypersensitivity).  
The specific aims of the five papers included in the thesis were:  
I Investigate quality of life in patients with subjective food hypersensitivity using the 10-item 
SF-NDI, after translating and validating the questionnaire to Norwegian. 
II Compare the prevalence and severity of SHC and MHW among patients with subjective 
food hypersensitivity and two groups of controls; health care workers and participants from 
the general population. 
III Compare the lifestyle in patients with subjective food hypersensitivity to an age- and sex 
matched group of volunteers from the general population.
IV Compare perceived job stress, demands and control in the workplace environment, and the 
use of specific coping strategies between patients with subjective food hypersensitivity and 
controls from the general population. 
V  Examine whether psychological factors such as gastrointestinal symptom-specific and 
general anxiety and depression could predict symptom severity in patients with subjective 
food hypersensitivity. For this purpose, the Visceral Sensitivity Index was translated and 
validated to Norwegian. 
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3. MATERIAL AND METHODS 
3.1 EXPERIMENTAL GROUPS 
3.1.1 Patients 
Paper I-V: Patients consecutively referred by primary physicians or specialist doctors at Haukeland 
University Hospital (Bergen, Norway) because of GI complaints self-attributed to food 
hypersensitivity and age above 18 years were eligible for inclusion in the study. Exclusion criteria 
were pregnancy or lactating, organic diseases that could explain their complaints, or serious 
anaphylactic reactions. Papers I, II, III include one group, paper IV a second, and paper V a third 
group of patients examined between 2001 and 2009. 
3.1.2 Controls
Papers I - III: Health care workers, mainly nurses working at Haukeland University Hospital, who 
were aged 25-62 years and without subjective food hypersensitivity (“healthy controls”), and 
persons randomly selected from the general population, sex- and age matched to the patients 
(“population controls”) served as control subjects. The health care workers were given written 
information about the studies and asked to participate. Participants from the general population 
were contacted after receiving permission from the Norwegian National Registry, using a 
randomized computer procedure. The persons were mailed a letter explaining the study and 
questioning whether they would like to participate. Those who gave a positive answer were mailed 
the questionnaires and a stamped envelope for return mail. The controls were not medically 
examined, and persons with perceived food hypersensitivity were not excluded. Papers IV includes 
a new group of volunteers selected from the general population following the same procedure as in 
paper I - III.  
3.1.3 Ethics 
The clinical trials were performed according to the Declaration of Helsinki (133). The Regional 
Committee for Medical Research Ethics and The Norwegian Social Science Data Services 
approved the studies. Paper I – IV: The patients and controls from the general population gave 
written informed consent. Controls of health care workers in paper I - II, and patients in paper V
received written information, and gave their consent by returning the filled-in questionnaires.  
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3.2 MEDICAL EXAMINATIONS  
• A complete medical history 
• Skin prick tests using 22 common food items and inhalants (ALK Abello, Hørsholm, 
Denmark)  
• Blood samples for determination of serum total IgE and food-specific IgE (CAP-FEIA-
System; Pharmacia, Uppsala, Sweden)  
• Elimination diet, open provocation, and double-blind placebo-controlled food challenges 
(DBPCFC) performed by a dietician 
• Hydrogen Breath Test (performed to exclude lactose malabsorption) 
• Upper gastrointestinal endoscopy, biopsies from the stomach and duodenum (to diagnose 
Helicobacter pylori infection and celiac disease, respectively)  
• Intestinal permeability of 51Cr-labeled ethylenediaminetetraacetic acid (51Cr-EDTA) and 
calprotectin in gut lavage fluid (used for excluding inflammatory bowel disease) 
• Microscopy and culture of stool samples (paper I-III) to rule out gastrointestinal infections 
• A screening questionnaire (based on Rome II criteria) applied for the diagnosis of functional 
bowel disorders like functional dyspepsia or irritable bowel syndrome 
3.3 QUESTIONNAIRES 
Table 2. Overview of study designs 
Papers Study design Time 
Total 
number of  
patients 
Patients 
withdrawing 
Participants 
included in the 
study* 
Questionnaires 
Paper I Case-control 
(MAI 1-2) 
2001 - 2003 n=68 n=16 (23.5%) 
P=52  
C=50 
C=70 
SF-NDI, GSRS, 
UESS 
Paper II Case-control 
(MAI 1-2) 
2001 - 2003 n=68 n=16 (23.5%) 
P=46 
C=50 
C=70 
SHC, MHW 
Paper III Case-control 
(MAI 1-2) 
2001 - 2003 n=68 n=16 (23.5%) P=46 
C=70 
Lifestyle  
Questionnaire 
Paper IV Case-control 
(MAI 3-4) 
2003 - 2006 n=113 n=17 (15%) P=64 
C=65 
SHC, CJSQ,  
D/C model, UCL 
Paper V Cross-sectional 
(MAI 5)
2007 - 2009 n=84 n=4 (6%) P=70 SHC, VSI, HADS, 
IBS-SQ 
*P = patients, C = controls  
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3.3.1 Short-Form Nepean Dyspepsia Index (SF-NDI) 
The 10-item SF-NDI was constructed and validated in patients with functional dyspepsia (134). 
Subsequently, it was validated in patients with subjective food hypersensitivity (5). The 10-item 
short form includes five subscales, namely, tension, interference with daily activities, 
eating/drinking, knowledge/control, and work/study. Each subscale contains two items. The items a 
measured on a 5-point graded Likert scale (1 = not at all, 2 = a little, 3 = moderately, 4 = quite a 
lot, 5 = extremely) (134). A total sum score for quality of life and a sum score for each of the five 
subscales were calculated by adding up scores for each item (range of total quality of life, 10–50; 
range of each subscale, 2–10). Higher scores indicate worse functioning or symptoms (134). The 
original questionnaire was translated from English into Norwegian, then back-translated into 
English by two translators. One of them had English as his native language. The two translated 
English versions were then compared with each other and with the original version, and the authors 
and the translators came to an agreement of the final Norwegian version. 
3.3.2 Gastrointestinal Symptom Rating Scale (GSRS) 
The questionnaire includes 15 items and uses a 7-point graded Likert scale defined by descriptive 
anchors (1 = no symptoms at all, 2 = minimal symptoms, 3 = mild symptoms, 4 = moderate 
symptoms, 5 = rather serious symptoms, 6 = serious symptoms, 7 = very serious symptoms) (135). 
Higher scores indicate more pronounced symptoms. The items are grouped into five subscales: 
abdominal pain syndrome (abdominal pain/discomfort, sucking sensations in the epigastria, nausea 
and vomiting), reflux syndrome (heartburn, acid regurgitation), indigestion (borborygmus, 
abdominal distension, eructation, increased flatus), diarrhoea (increased passage of stools, loose 
stools, urgent need for defecation), and constipation (decreased passage of stools, hard stools, 
feeling of incomplete evacuation). The original rating scale is interview-based, but it was modified 
and used as a self-administered questionnaire in later studies (135). A Norwegian version of  the 
GSRS was used in this study (136).
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3.3.3 Ulcer Esophagitis Subjective Symptoms Scale (UESS) 
The UESS was developed to quantify the symptoms frequently experienced by patients with peptic 
ulcer and esophagitis (137). The questionnaire comprises 9 items, and a 100 mm Visual Analogue 
Scale (VAS) is used to quantify the symptoms. The items are grouped into four subscales: 
abdominal discomfort (abdominal pain, sucking sensation), reflux discomfort (acid regurgitation, 
heartburn), intestinal discomfort (abdominal distension, borborygmus), and sleep dysfunction
(difficulty falling asleep, insomnia, rested waking up). Higher scores indicate more pronounced 
symptoms (137). A Norwegian version of  the UESS was used in this study (138).
3.3.4 Subjective Health Complaints (SHC) 
SHC were measured by 29 items concerning subjective, somatic and psychological complaints 
experienced during the last 30 days (89). The degree of each complaint is rated on a 4-point scale 
(0 = not at all; 1 = a little; 2 = some; 3 = severe). The questionnaire is categorised into five 
subgroups: musculoskeletal pain (headache, migraine, neck pain, arm pain, shoulder pain, upper 
back pain, low back pain and leg pain), pseudoneurology (tiredness, sleep problems, anxiety, 
sadness/depression, extra heartbeats, heat flushes, and dizziness), gastrointestinal problems (gas 
discomfort, abdominal discomfort, diarrhoea, constipation, gastritis/ulcer, heartburn, and stomach 
pain), allergy (allergies, breathing difficulties, eczema, and asthma), and flu (cold/flu and 
coughing) (89). 
3.3.5 Modern Health Worries Scale (MHW) 
The scale was developed to assess how concerned the respondents were about the effects of 
different aspects of modernity on their personal health (122). The MHW Scale has four subscales: 
“toxic interventions” including seven questions on both medical items and vaccination programs as 
well as dangers seen by individuals in toxic chemicals in household products, “environmental 
pollution” including eight questions about air pollution and depletion of the ozone layer, six 
questions about “tainted food” such as genetically modified food and hormones, additives, 
pesticides, and antibiotics in food, and finally, “radiation” including six items about topics such as 
radio or cell phone towers and high-tension power lines. Each item is rated on a 5-point scale, 
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ranging from “no concern” to “extreme concern”. The total score is the sum of all 27 questions in 
the scale (122). 
3.3.6 Lifestyle Questionnaire  
The questionnaire is similar to one used by the Adventist Health Study at the Loma Linda 
University Medical Center in California (139). The modified Norwegian version is not formally 
validated but is cited in previous studies found to work well in patients with GI diseases (136; 140). 
The questionnaire consists of 72 questions with Likert scores ranging from “1” to “7” or “yes” and 
“no” for answers. The participants were asked whether they were hypersensitive to coffee, alcohol, 
orange juice, milk, fried foods, fruit, spicy foods, whole grain bread, tomatoes, fruits, raw 
vegetables, berries, or other foods. If they answered “yes” to at least one of the questions, they were 
classified as being food-hypersensitive (136). Furthermore, they were asked about the use of non-
steroidal anti-inflammatory drugs during the previous week, rated once per week or more often, and 
consumption of alcohol during the past year. The patients and the controls were asked whether they 
were active smokers, ex-smokers, or non-smokers, and for active smokers, the number of cigarettes 
per day. The remaining part of the questionnaire focused on meal patterns, eating habits, daily 
intake of fluids, exercise, and sleep during the last month. 
3.3.7 Cooper Job Stress Questionnaire (CJSQ) 
Job stress was measured using 22 questions of Cooper’s Job Stress Questionnaire scored on a 6-
point scale grading the amount of stress from 0 ( no stress at all) to 5 ( a lot of stress) (141). The 
questionnaire has four subgroups: communication (eight items related to lack of communication, 
conflicts with management and co-workers, and the relation between different groups of 
employees), leadership (four items related to the employee’s relationship to management, the 
amount of pay, feeling of being undervalued, and the possibilities for promotion), relocation (four 
items referring to how to guide the employees, the stress caused by promotion prospects, relocation 
and taking work home), and workload (five items measuring perceived time pressure, deadlines 
stress, workload, making mistakes, and stress due to work-influence on private life). 
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3.3.8 Demand, control and psychological factors in the work environment (D/C model) 
Demands and control, and psychosocial factors in the work environment were investigated by 11 
and six questions, respectively, from the short Swedish version of psychological demands 
dimension and the decision latitude dimension from the Demand/Control Model by Karasek 
and Theorell (108; 142). The demand and control questions are scored on a 4-point scale ranging 
from 1 to 4 (1 = no, practically never; 2 = no, rarely; 3 = yes, sometimes; 4 = yes, often), yielding 
a sum score for psychological demands and control. High demands (five questions) are related to 
working hard and fast, conflict with demands, or insufficient time to work. High scores represent 
high demands. The six questions on job control are related to task variety, learning new things, and 
freedom to decide on how to do the work. High scores indicate high control. The questions which 
examined psychosocial factors in the work environment have response alternatives ranging from 1 
to 4 (1 = failing; 2 = moderate correct; 3 = pretty correct; 4 = correct). The factors deal with the 
atmosphere on the workplace, how people take care of each other, and the relationship between 
leaders and colleagues (108). High scores indicate work well-being.  
3.3.9 Utrecht Coping List (UCL) 
Coping was examined by the Norwegian short version, the CODE, based on coping strategies from 
the UCL which consists of 47 statements about how to cope with problems and unpleasant 
situations (143).  In this study we have used 22 of the statements, which implies an instrumental, 
active, goal-oriented coping style with strategies like active problem solving (seven items involving 
behavioural-like intervention or making several alternative plans), avoidance and passive
expectancy (eight items implying passivity and avoidance, the problems may solve themselves), 
and depressive reaction patterns (seven items concerning being pessimistic and having a feeling of 
helplessness, worrying about the past and taking anti-depressive drugs). Each statement is rated on 
a 4-point scale (1 = hardly ever; 2 = sometimes; 3 = often; 4 = very often). High score on 
instrumental mastery oriented coping is attained by high scores on active problem solving and low 
scores on avoidance and passive expectancy and depressive coping (144). Individuals with a high 
score on this factor do not avoid difficult situations and look at the problem as a positive challenge 
(143).  
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3.3.10 Visceral Sensitivity Index (VSI)  
The VSI is a 15-item self-report gastrointestinal symptom-specific anxiety questionnaire 
comprising five dimensions of gastrointestinal-related cognition and behaviours: worry, fear, 
vigilance, sensitivity and avoidance (145; 146). Item generation is based on considerations 
regarding stimulus origin as well as affective, cognitive, or behavioural manifestations of the 
dimensions. The items are ranged from 1 = strongly agree to 6 = strongly disagree, but are 
reverted (i.e., 1-6 becomes 5-0) so that high scores indicate high symptom-specific anxiety (146). 
The questionnaire yields a range of possible scores from 0 (no gastrointestinal-specific anxiety) to 
75 (severe gastrointestinal-specific anxiety). The original questionnaire was translated from English 
into Norwegian, then back-translated into English by two translators. One of them had English as 
his native language. The two translated English versions were then compared with each other and 
with the original version, and the authors and the translators came to an agreement of the final 
Norwegian version. 
3.3.11 Hospital Anxiety and Depression Scale (HADS)
The HADS is a self-assessment mood scale consisting of 14 items, 7 for the HADS-A (anxiety) and 
7 for the HADS-D (depression) (147). Each item is rated from 0 (not present) to 3 (maximum). The 
scale has been extensively validated and is well accepted in both psychiatric and non-psychiatric 
settings (148). In this study, two groups of psychopathology were defined: case level anxiety 
(HADS-A  8) and case level depression ((HADS-D  8), which is based on commonly accepted 
cut-off values on HADS (148). 
3.3.12 Irritable Bowel Syndrome Symptom Questionnaire (IBS-SQ) 
The questionnaire IBS-SQ examines the severity of six gastrointestinal symptoms: nausea, 
bloating, abdominal pain, diarrhoea, constipation and anorexia, and is rated on a scale from 0 (no
symptoms) to 10 (severe symptoms) (149).  
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3.4 STATISTICS 
3.4.1 Psychometric properties of questionnaires  
Reliability is the extent to which a measure is stable or consistent and produces similar results when 
administered repeatedly (150; 151). In paper I and V test-retest reliability was determined by both 
limits of agreements according to Bland and Altman (150), and Pearson correlating test after 
administering the questionnaires to the same persons 4 weeks apart.  If the correlation between 
separate administrations of the test is  0.7, then it has good test-retest reliability (150; 151). Bland 
and Altman’s plots for limit of agreement (useful when there are only two raters) is to calculate the 
mean of the differences between the two raters (151). The confidence limit around the mean 
provide insight into how much random variation may be influencing the ratings (151). Cronbach 
alfa, which was used in the Norwegian version of the VSI in paper V, is a coefficient (a number 
between 0-1) that rates the internal consistency or reliability of items in the questionnaire. A test 
has a strong internal homogeneity when correlation among items is  0.7 (152). 
Validity is the degree to which an instrument measures what it is intended to measure (150; 151). 
There are two main forms of validity: internal and external validity. Internal validity refers to the 
internal structure of a questionnaire and may be done in four different ways; factor analysis, 
convergent and discriminant validity, and floor–ceiling effects (150; 151). Factor analysis, which 
was used in paper V, is a statistical method that describes variability among observed variables in 
terms of fewer unobserved variables called factors. External validity is the relationship between the 
test and the external criteria such as other measures of the same or other dimensions of the 
measurement, and is measured by face, content, construct and criterion validity (150; 151). In paper 
I and V we used face validity, which denotes whether the questions “make sense”, and is assessed 
by having patients and “experts” reviewing the contents of the questionnaire to see if the items 
seem related to the topic that is going to be investigated. In paper I construct validity, reflecting the 
ability of an instrument to measure an abstract concept or construct, and the extent to which a 
measure under investigation provides results that are consistent with the theories that are assessed, 
was evaluated by correlating scores in the SF-NDI with scores in the GSRS and UESS. Known-
groups validity is a form of construct validation in which the validity is determined by the degree to 
which an instrument can demonstrate different scores for groups known to vary on the variables 
being measured (150; 151). In paper V this validity were done by correlating VSI with patients 
reporting IBS-SQ scores < 25 and IBS-SQ scores  25, and HADS-A scores <8 and HADS-A 
scores 8. We also used concurrent validity, evaluating the degree to which two or more measures 
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that theoretically should be related to each other, in fact, observed to be related to each other, 
correlating VSI and HADS-A.  
Responsiveness is the ability of an instrument to detect clinically important changes (153). There 
are two major aspects of responsiveness, the internal responsiveness that characterizes the ability of 
a measure to change over a particular specified time frame, and the external responsiveness which 
reflects the extent to which changes in a measure over a specified time frame relate to 
corresponding changes in a reference measure of health status (154). In paper I, responsiveness was 
tested by correlating changes in SF-NDI total score over 4 weeks with the corresponding symptoms  
changes in GSRS total score.  
3.4.2 Statistics (Paper I-V) 
All statistic calculations and graphic designs were performed using the Graphpad Prism 4.0 and 5.0 
(GraphPad Software Inc, San Diego, USA) and SPSS 16.0 for Windows (SPSS Inc., Chicago, IL) 
statistical software package. The values are given as mean ± SD (paper I, III IV and V) and median 
with interquartile range (paper II and III) according to distribution of data. Differences between 
means were calculated with parametric tests for data normally distributed, and non-parametric tests 
for data not normally distributed. Pearson`s correlation coefficient was used for correlation 
analysis. Influence of psychological factors on somatic symptom severity was studied by multiple 
regression analysis. All tests were two-tailed, and P < 0.05 was chosen as the level of statistical 
significance.  
Differences between groups were evaluated using: 
Paper I: One-way ANOVA and unpaired t test 
Paper II: Kruskal-Wallis test and odds ratios (OR), with 95% confidence interval (95% CI) 
Paper III: Chi-square test and OR (95% CI) and unpaired t test  
Paper IV: Unpaired t test, OR (95%CI), and Fisher`s exact test 
Paper V: Unpaired t test 
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4. SUMMARY OF RESULTS  
4.1 PAPER I  
Quality of Life in Patients with Subjective Food Hypersensitivity: Applicability of the 10-Item 
Short Form of the Nepean Dyspepsia Index 
The patients (n = 52) reported poor quality of life compared with controls of health care workers 
(n=50), (P<0.001) and participants from the general population (n = 70), (P < 0.001). The SF-NDI 
provided reliable, responsive, and clinically valid measures of quality of life in these participants.
Scores on SF-NDI were significantly correlated with scores on the GSRS (r = 0.34, P = 0.02) and 
UESS (r = 0.41, P = 0.003). Food hypersensitivity was confirmed in four patients, and the quality 
of life impairment was similar in the patients who had verified compared to those who had 
subjective food hypersensitivity. Thirty-four (65%) of the patients reported having atopic disease 
(rhinoconjuctivitis, atopic dermatitis, urticaria, asthma, and/or oral allergic syndrome) in addition to 
the food hypersensitivity. 
4.2 PAPER II  
Subjective Health Complaints and Modern Health Worries in Patients with Subjective 
Food Hypersensitivity 
The patients (n = 46) reported more frequent and severe health complaints than healthy controls   
(n = 50) (P < 0.0001) and volunteers from the general population (n = 70) (P < 0.0001). The 
patients scored significantly higher than controls on sum scores for four domains of the SHC 
including gastrointestinal complaints (P < 0.001), musculoskeletal complaints (P < 0.01), 
“pseudoneurology” (P < 0.001), and allergy (P < 0.001). Total sum scores on the MHW scale did 
not differ significantly among the groups. The patients were significantly more worried about
overuse of antibiotics (P < 0.001), amalgam in dental fillings (P < 0.01), and additives in food  
(P < 0.05), and genetically modified food (P < 0.05). None of the patients had IgE-mediated food 
allergy according to generally accepted definition (40). Two patients had non-IgE mediated food 
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hypersensitivity to egg and yeast/wheat flour, respectively, with a positive DBPCFC but a negative 
skin prick test and/or specific IgE in serum. 
4.3 PAPER III  
Lifestyle of Patients with Self-Reported Food Hypersensitivity Differ Little From Controls 
All (n = 46) of the patients and 43% (n = 30) of the controls reported adverse reactions to one or 
more foods (P = 0.0001). The patients reported intolerance to a mean of 4.0 (range 1–9) food items 
compared with 2.0 (range 1–3) among the controls. Except for coffee, a significantly greater part of 
the patients reported hypersensitivity for all the 12 food items mentioned in the questionnaire. 
Fruits, milk, orange juice, and raw vegetables were the most common foods to which the patients 
reported intolerance. The controls avoided fruits, coffee, orange juice, and spicy foods. In the 
category “other foods” causing intolerance, the patients reported wheat and eggs compared with the 
controls who reported peanuts and fatty foods. Significantly fewer patients (72%) than controls 
(94%) reported use of alcohol the last year (P = 0.008). Eating habits, meal patterns, hours of sleep 
per night, the amount of exercise per week, and use of painkillers during the last month were 
similar in both groups.  
4.4 PAPER IV  
Job stress and coping strategies in patients with subjective food hypersensitivity 
Compared to controls (n = 65), patients (n = 64) scored significantly lower on job stress (P = 0.01) 
and job demands (P = 0.04), and significantly higher on authority over job decisions (P = 0.04). 
Generally, the participants were satisfied with the work environment, and they reported similar  
active coping pattern like the controls scoring high on instrumental mastery oriented coping; high 
on active problem solving and low on avoidance and passive expectancy and depressive coping. 
The patients reported significantly more SHC than the controls(P = 0.0001) where the five most 
dominant complaints were: gas discomfort (95%), diarrhoea (86%), stomach discomfort (84%), 
tiredness (84%) and headache (69%). The main complaints in the control group were tiredness 
(71%), headache (69%), neck and low back pain (51% and 46%, respectively) and gas discomfort 
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(48%). Patients (44%) working part time reported significantly more SHC than those who were full 
time employed (P = 0.0005). In the control group, there was no such significant difference. None 
were diagnosed as having celiac disease or any other organic GI illness. IgE-mediated allergy to 
egg was diagnosed in one patient and non-IgE-mediated allergy to wheat flour in another. Forty-
nine (76.5%) of the patients were diagnosed having IBS according to the Rome II-short criteria. 
4.5 PAPER V  
Do psychological factors predict symptom severity in patients with subjective food 
hypersensitivity? 
The study included 70 patients with subjective food hypersensitivity. In the multiple regression 
analysis neither GI nor non-GI symptom severity were significantly correlated to scores on 
psychological factors when these were considered together, P = 0.08 and P = 0.68, respectively. 
Adding age to the model, increased the amount of explained variance in non-GI symptom severity 
from 2.2% to 11.3% (P = 0.10), while the amount of explained variance in GI symptom severity 
remained unchanged (9.4%, P = 0.16). In the final model (including age), the VSI was a significant 
predictor for GI symptom severity (P = 0.02), but not for non-GI symptom severity (P = 0.48). Age 
was the sole significant predictor of non-GI symptom severity (P = 0.01), whilst GI symptom 
severity was not predicted by age (P = 0.85). One patient had positive skin prick test (in addition to 
elevated serum specific IgE) for one food allergen (wheat). However, DBPCFC could not confirm 
food allergy in any of the patients. Among the 70 patients included, 66 (94%) had IBS according to 
the Rome II criteria. The Norwegian version of the VSI had satisfactory validity. 
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5. GENERAL DISCUSSION 
5.1 QUALITY OF LIFE, SUBJECTIVE HEALTH COMPLAINTS AND MODERN 
HEALTH WORRIES (PAPER I AND II) 
We rarely found indications of food allergy in patients with GI complaints self-attributed to food 
hypersensitivity. This is consistent with the findings of others (155; 156). When the food 
hypersensitivity remained unexplained following a structured medical work-up, we denoted the 
condition subjective food hypersensitivity (5). More than 90% of these patients presented with IBS-
like symptoms.  Bloating, abdominal pain and altered stool pattern were the most prominent 
symptoms (5; 157). However, many patients also reported a number of non-gastrointestinal 
symptoms such as fatigue, anxiety, depression, musculoskeletal pain and sleep disorders (6), and 
some patients felt “sick all over”. 
Compared with controls, the patients reported considerably impaired QoL (5). This is in accordance 
with previous studies of people suffering from perceived food hypersensitivity and IBS (158; 159). 
Spiegel et al. (160) recently evaluated the determinants of both mental and physical health related 
QoL in 770 IBS patients recruited both by advertisement and as tertiary referrals at a university-
based centre. Fatigue, low “energy”, painful symptoms, feeling nervous and hopeless were factors 
influencing their QoL (160). Several studies have reported that these patients also contact general 
practitoners, medical specialists, and alternative healers more frequently than the general 
population (1; 53; 161). Research is most often conducted in hospital settings, but also in 
population-based studies (162) people with food hypersensitivity and IBS experienced significant 
impairment in health related QoL compared with population-based controls. 
Generally,  IBS patients report QoL impairment that is equal or greater than that seen in   
individuals with asthma, migraine or gastroesophagal reflux disease (158). Even compared with 
serious chronic conditions like diabetes mellitus and end-stage renal disease, the IBS patients report 
lower values in several aspects of QoL (159). Consistent with our findings, numerous co-exiting 
symptoms seem to be particularly associated with worse QoL (87). The impact of functional GI 
disorders on QoL is often underestimated by health care workers because people with these 
disorders do not face direct threat to their life and are not disabled in any obvious way. For the 
same reason, friends and family members of individuals with functional GI disorders may 
underestimate the impact these disorders can have on a person. The Norwegian version of the 
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instrument for assessment of QoL performed satisfactory in patients with subjective food 
hypersensitivity (5).  
In this thesis, altogether 180 patients and 185 controls (paper II, IV and V) were examined using 
the Subjective Health Complaint Inventory. The patients reported significantly more SHC from 
different organ systems compared with controls, especially GI complaints, and anxiety and 
depression. There is an extensive literature relating IBS and other medically unexplained physical 
symptoms, including subjective food hypersensitivity, to anxiety and depression. However, to what 
extent psychological factors explain symptom severity in the patients is still not clear (7; 163; 164). 
The majority of our patients were offended when the possibility of psychological factors, as a 
contributor to their complaints, was discussed (165). That patients often form own ideas about their 
illness (166), which may lead to a vicious circle in which somatic causal assumption leads patients 
to be more preoccupied with their bodies and more aware of their symptoms. Patients with verified 
food allergy are often well safeguarded by the health care workers, while the majority with 
unexplained functional disorders often feel that they are neglected and therefore forced to seek help 
from alternative medicine (167). There it may be easier to get a “diagnosis” and accept for their 
ideas about their illness, but in many cases alternative treatment usually has short-lasting effect and 
can be very expensive for the patients (168; 169). Many patients know that presenting IBS-like 
symptoms does not result in much help from physicians or other health care professionals (61). 
Some physicians even deny the very existence of the functional GI disorders, whereas others show 
dismissive or negative attitudes toward patients (170; 171). On the other hand, rather than being 
relieved to hear that “nothing is wrong”, patients may become angry, and even resentful, and 
demand further tests, which  may pursue unnecessary diagnostic studies to find something “real” 
(172), resulting in increased health care costs and possibly inappropriate care (173).  
It has been argued that the boundaries of medically unexplained symptoms largely coincide with 
the current limits of medical knowledge (174), and diseases outside these limits are often given 
psychiatric explanations, like somatisation disorders. At once the physician even “knows” what 
caused all the symptoms, which is in fact rarely the case in somatic medicine. Also, the “resistance” 
against the diagnosis is often taken as confirmation that it is correct, which according to our 
experience often is the case in subjective food hypersensitivity patients. Also, a diagnosis of 
somatisation may not be an innocuous label because it may close various doors and lead the 
planning of treatment into track that may gets nowhere (174). 
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A large body of research has documented the role of stressful life events and repeated or chronic 
environmental challenges in vulnerability to illness (175), and the tendency to experience and 
communicate psychological distress in the form of physical symptoms and to seek medical help for 
them is a widely accepted concept. When there is a circular relationship between different causal 
factors, it is difficult to know what the cause of the symptoms is. In the end, we are all biological 
beings, and further studies are eagerly needed to resolve whether the psychological factors are the 
cause or consequence of IBS, or whether they are simply parallel manifestation of an underlying 
disorder. 
MHW have been associated with SHC and health care use (176). However, in the current study, the 
patients did not report more MWH than controls. Our patients with subjective food hypersensitivity 
were concerned about specific food items, not about food in general or, for instance, the influence 
of modern life on health. Hence, MHW seems to have no influence on the number or severity of 
SHC reported by our patients. The participants` age may influence the results. A previous study 
utilizing a more diverse age range found that older individuals reported less concern regarding 
modernity than younger persons (177). Furthermore, the patients` strong assumptions with regards 
to the cause of their symptoms may also play an important role in the low scores on the MHW 
scale. 
50
6.2 LIFESTYLE, JOB STRESS AND COPING STRATEGIES (PAPER III AND IV) 
The lifestyle of patients with subjective food hypersensitivity differed little from controls, which is 
consistent with other quantitative studies about lifestyle in similar patient groups (178; 179). 
Peveler et al. (179) found that 12% of people with perceived food hypersensitivity reported 
moderate or great influence on activities of daily living such as housework, social life, eating out, 
and physical activity, while Knibb et al. (178) reported that 17% of the food-intolerant interviewers 
attributed effects on lifestyle. In qualitative research, however, patients reporting food 
hypersensitivity and IBS often claim considerable influence on lifestyle, especially on dietary 
ingredients and meals, stress, sleep and physical activities in efforts to improve symptoms (180; 
181). In a study by Jarret et al. (180),  women with subjective food hypersensitivity and IBS 
developed self-care strategies including eating once a day, fasting for short periods or having small 
meals in non-stressful situations. The women spent quite a lot of time identifying offending food, 
still the process was not always successful. Very few patients, only four percent, sought dietary 
advice from physicians, dieticians or nurses (178), perhaps because they knew that the health care 
professionals could not help. Many patients felt quite helpless because of the infrequent and 
unpredictable symptoms (180). 
None of the included patients had lactose malabsorption or positive DBPCFC with milk, still 
significantly more patients than controls offended milk. A possible explanation may be that many 
patients had been told, from childhood, that they were intolerant to milk, which may have 
convinced them that milk is the cause of their food hypersensitivity. In our study less patients than 
controls used sweets, coffee, and alcohol, which are known to cause gastrointestinal symptoms in 
some sensitive individuals (79; 80). Interestingly, there were no difference between patients and 
controls in consumption of fermentable whole-grain bread, fruits, and raw vegetables that recently 
have been implicated  in symptom generation in patients with IBS (79). This may be due to lack of 
knowledge or because the Norwegian health authorities insist that such food items are healthy and 
beneficial (182).   
The fact that 43% of the controls reported hypersensitivity to at least one food item may be due to 
an increased prevalence of  food hypersensitivity in the general population (183), or because of the 
public and medical interest in the topic. Clearly, this high prevalence of perceived food 
hypersensitivity in the general population makes it difficult to document differences between 
patients and controls. The controls were not medically examined; therefore, we do not know 
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whether their perceived food hypersensitivity represent a real allergy or not. The results from the 
questionnaires indicate that the controls perceived themselves as more healthy than the patients, 
reporting a better QoL and significantly fewer SHC than the patients. Nevertheless, the patients and 
controls slept on average the same number of hours per night, and their exercise pattern and use of 
pain killers were similar. One explanation may be that about 40% of the patients experienced that 
exercising improved their symptoms, which may cause better sleep. 
It is well known that stress may aggravate GI disorders (54; 180) and may also play a role in the 
pathogenesis of hearth disease, musculoskelestal pain and depression (109; 110). Whether a 
person’s job is perceived as stressful depends on work environment, social support, feeling of being 
in control of the situation, and coping mechanisms (105; 108). Karasek (108) hypothesise that high 
job demands and low control carries the highest risk of illness and disease did apparently not imply 
to our patients who reported significantly lower scores on job stress and significantly higher scores 
for authority on job decision and control than the participants from the general population. 
Furthermore, the patients and controls were equally satisfied with their job environment. Jones et 
al. (184) showed that the dominant coping strategies in patients with gastrointestinal complaints 
such as IBS or inflammatory bowel disease (IBD) were more on escape and avoidance strategies 
than planned problem solving, but our patients used similar problem-solving coping, e.g., positive 
response expectancies like the controls. The results suggest that job stress and coping strategies 
have a weak impact on patients with subjective food hypersensitivity and IBS. One explanation 
may be that patients who report adverse food reactions are mostly women (6; 185), often being 
part-time workers. Nearly half of the patients (44%) and  32% of the controls worked 50% of full 
time, which may contribute to less perceived job stress in general (92; 97). Another explanation 
may be that the patients` somatic complaints, especially the GI complaints, prevented them from 
seeking stressful jobs or leading positions.  
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6.3 ROLE OF PSYCHOLOGICAL FACTORS (PAPER V) 
In the fifth paper we investigated whether psychological factors such as symptom-specific and 
general anxiety, and depression could predict somatic symptom severity in patients with subjective 
food hypersensitivity and IBS. The presence of multiple co-morbid disorders has been suggested as 
a marker for psychological influences on etiology (186). In the present study, 24% of the patients 
reported anxiety and 14% depression on the HADS questionnaire, which is in accordance with a 
previous study of a similar patient material were anxiety disorders (34%) and depression (16%) 
were the predominant psychological factors (163). In the present study, however, psychological 
factors explained, when considered together, only approximately 10% of the variance in the 
patients` symptom severity; hence, 90% of the variance remained unexplained. 
Stress and negative expectancies are, in general, assumed to be causally related to symptom 
severity and to play an important role in the development of multiple SHC (187). In patients with 
subjective food hypersensitivity, fear of symptoms after eating a meal could represent a 
considerable stress factor, in particular, if associated with beliefs of poor symptom control. We 
therefore made a new questionnaire with 4 negative and 4 positive statements related to more or 
less unpredictable reactions in response to food intake and coping capabilities (Appendix I, page 
71). Dividing sum scores for negative by sum scores for positive expectancies gave an individual 
“weighted” ratio referred to as the expectancy to food (ETF) score. Interestingly, in our patients 
positive and negative expectancies almost balanced each other, giving a mean ratio of negative to 
positive expectancies of (1.3 ± 0.59), not significantly different from 1.0 (unpublished results). The 
low ETF and weak influence of negative outcome expectancies on symptoms may be related to 
these patients’ strong belief in own attribution and coping capabilities. It is also worth noticing that 
our patients were free from symptoms during fasting and during the night (unpublished results). 
These symptom-free periods conceivably provide a window with possibilities of restitution, an 
important aspect of coping (188), besides being a sound argument favouring the patients’ belief that 
food is the culprit. 
ETF scores were strongly correlated to the VSI (P = 0.0001), probably because they both measure 
the same dimension (Appendix II, page 72). As a consequence, we gave the established VSI 
priority in the regression analysis and the ETF results were not published. However, several things 
can be learned from our ETF results. First of all, the influence of expectancies on health apparently 
depends on the balance between negative (hopelessness) and positive (coping) outcome 
53
expectancies as also shown previously (189). This balance is not accounted for by the VSI, which 
primarily measures aspects of anxiety related to expected symptoms. In the present study, this 
“gastrointestinal symptom-specific anxiety” was the sole independent psychological predictor of 
gastrointestinal symptom severity explaining approximately 7% of the variance in gastrointestinal 
symptoms (P = 0.02). The results agrees with prior studies where the VSI was significantly related 
to the presence and severity of IBS (145; 146; 190), which also indicate that our Norwegian version 
of the VSI have excellent consistency and  reliability (151). The VSI correlated significantly with 
GI symptoms and general anxiety scores, but general anxiety explained only 1.3% of the variance 
in GI symptoms, suggesting that general anxiety is even less important for symptom generation 
than symptom-specific anxiety in these patients. Age was the sole predictor of non-abdominal 
symptoms, which seemingly were largely unrelated to psychological factors. Hence, our results 
suggest that the pathophysiology of subjective food hypersensitivity may depend less on 
psychology and more biology than previously thought.  
ETF and VSI are both measures of expectations of symptoms in response to food intake. To call 
these expectations “symptom-specific anxiety”, as done in the VSI, may be a misnomer, misleading 
the reader to think that anxiety is the primary cause of the problems. Our ETF results suggest, on 
the contrary, that the symptoms reported by the patients have little to do with anxiety, but rather to
reasonable expectancies. The high prevalence of anxiety among patients with subjective food 
hypersensitivity tells nothing about causality. It may as well be that unpredictable food reactions 
cause anxiety, or it may be a third, external factor causing both problems independently. Twenty 
years ago peptic ulcer patients faced a similar problem. Their disease was also associated with a 
high prevalence of anxiety, and therefore classified as a psychosomatic disorder (191; 192). After 
the discovery of Helicobacter pylori, the diagnosis and treatment of the disease changed 
dramatically (193), and a 10 years’ follow-up study of cured ulcer patients showed complete 
disappearance of the psychological problems in the near 100% relapse-free patients. Hence, in the 
case of peptic ulcer disease, the psychological problems were clearly a consequences, not a cause of 
the disease (194).  
A number of recent studies have provided evidence of immune activation (e.g., release of 
cytokines, histamine, and proteases) in the intestinal mucosa of IBS patients (56; 195; 196).
Conditions that are known to predispose to IBS, such as enteric infection, antibiotic use, and stress, 
may all change the intestinal microbiota (56), which in turn may trigger local and systemic immune 
activation, low-grade mucosal inflammation, increased intestinal permeability, and disturbances of 
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intestinal motility and fermentation (197). More than 60% of consecutive patients referred to our 
interdisciplinary team for evaluation of food hypersensitivity have atopic disease, and these atopic 
patients have significantly more “IgE-armed” mast cells in their duodenal mucosa and increased 
intestinal permeability compared with non-atopic patients (198). The clinical significance of this 
new exciting finding is not yet clear and more research is required to disclose the role of “IgE-
armed” mast cells and intestinal permeability in patients who usually have negative DBPCFC, 
which until now has been regarded as the gold standard for diagnosing food hypersensitivity (26). 
Interestingly, we have recently shown that joint and bodily pain is attenuated following enteral 
(tube) administration of seal oil to the duodenum (199). Systemic manifestations (co-morbidities) 
in subjective food hypersensitivity often regarded as psychiatric somatisation doesn’t fit with a 
rapid (within 10 days’) effect of seal oil administration, an effect supposed to be due to suppression 
of prostaglandin E2 production by the administrated omega-3 PUFA. Earlier, we have shown a 
similar rapid effect of duodenally administered seal oil in patients with IBD related joint pain (200). 
The recent finding of increased concentrations of BAFF (B-cell activating factor) in blood and 
intestinal lavage from our patients (201) supports the concept of immune activation in patients with 
subjective food hypersensitivity. 
Recent articles indicate that IBS patients have normal production of intestinal gas (202), but high 
concentrations of  short chain fatty acids in feces (203; 204). In patients with post-infectious IBS 
following cure of Gardia lamblia infection, total fecal excretion of short chain fatty acids was 
increased (205). Several of these patients also had increased fecal excretion of fat, indicating 
intestinal malabsorption (205). A possible mechanism of increased fecal excretion of short chain 
fatty acids is that the fermenting flora in the coecum is impaired or overwhelmed. Fermentation of 
carbohydrates may thus continue along the entire colon until the rectum, creating flatulence and 
abnormal amounts of unabsorbed short chain fatty acids in feces. (Short chain fatty acids are 
produced of microbial fermentation and normally quickly absorbed from the colon, leaving only 
around 5% to be excreted). Our working hypothesis is that IBS-like symptoms in patient with 
subjective food hypersensitivity is due to altered small intestinal motility (stress, allergy), causing 
malabsorption of carbohydrates, and sometimes even fat (206). Consistently, reducing the demands 
on intestinal fermentation by a diet low in carbohydrates alleviates the symptoms (207; 208). 
Further dietary studies are eagerly awaited because an effective treatment could elucidate the 
unresolved problem of whether psychological factors are the cause or consequence of IBS, or 
whether they simply are parallel manifestations of an underlying disorder. 
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6. CONCLUSIONS  
6.1 INDIVIDUAL PAPERS 
Paper I: Compared with controls the patients reported an impaired quality of life. Validation of the 
Norwegian version of the SF-NDI questionnaire showed satisfactory psychometrics.  
  
Paper II: The patients reported significantly more SHC than the controls. The patients were 
concerned about some specific food items, but they did not report more modern health worries than 
the controls.
Paper III: Lifestyle differed little between patients and controls. The patients reported 
hypersensitivity to more food items, and they used less milk, coffee and alcohol than the controls. 
  
Paper IV: The patients reported more SHC than the controls, but significantly lower scores on job 
stress and significantly higher scores for authority on job decision and control. Patients and controls 
were equally satisfied with the job environment, and they used similar coping strategies for solving 
problems and difficult situations. The results suggest that job stress and coping strategies have little 
impact on all the patients` health complaints.
Paper V:  The psychological factors explained only 10% of the variance in the patients` symptom 
severity; hence 90% of the variance remained unexplained. Gastrointestinal symptom-specific 
anxiety was the sole independent psychological predictor of GI symptom severity, while age was 
the sole predictor of non-GI symptoms. The Norwegian version of the VSI demonstrated 
satisfactory validity and reliability.  
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6.2 OVERALL CONCLUSIONS 
The thesis suggests that patients with subjective food hypersensitivity and IBS have impaired 
quality of life. The patients report more anxiety, depression and SHC from different organ systems 
compared with controls. On average 90% of the patients present with symptoms consistent with 
IBS. The small lifestyle differences between patients and controls are most likely a consequence 
and not a cause of the complaints. Neither lifestyle nor job stress or coping strategies could explain 
the patients` SHC, and psychological factors explained only approximately 10% of the variance in 
the patients` symptom severity.   
The pathophysiology of these patients’ suffering may be more biologic and less psychologic than 
previously thought. Further interdisciplinary, translational research on food allergy, immune 
activation, intestinal absorption and motility, and intestinal microbiota are warranted in patients 
with subjective food hypersensitivity.  
57
REFERENCES 
 1.  Bhat K, Harper A, Gorard DA. Perceived food and drug allergies in functional and organic 
gastrointestinal disorders. Aliment Pharmacol Ther 2002;16:969-973. 
 2.  Sicherer SH. Food allergy. Lancet 2002;701-710. 
 3.  Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, 
Kowalski ML, Mygind N, Ring J, van Cauwenberge P, Hage-Hamsten M, Wuthrich B. A 
revised nomenclature for allergy. An EAACI position statement from the EAACI 
nomenclature task force. Allergy 2001;56:813-824. 
 4.  Osterballe M, Hansen TK, Mortz CG, Høst A, Bindslev-Jensen C. The prevalence of food 
hypersensitivity in an unselected population of children and adults. Pediatr Allergy 
Immunol 2005;16:567-573. 
 5.  Arslan G, Lind R, Olafsson S, Florvaag E, Berstad A. Quality of life in patients with 
subjective food hypersensitivity: applicability of the 10-item short form of the Nepean 
Dyspepsia Index. Dig Dis Sci 2004;49:680-687. 
 6.  Lind R, Arslan G, Eriksen HR, Kahrs G, Haug TT, Florvaag E, Berstad A. Subjective health 
complaints and modern health worries in patients with subjective food hypersensitivity. Dig 
Dis Sci 2005;50:1245-1251. 
 7.  Hausteiner C, Bornschein S, Bubel E, Groben S, Lahmann C, Grosber M, Löwe B, Eyer F, 
Eberlein B, Behrendt H, Darsow U, Ring J, Henningsen P, Huber D. Psychobehavioral 
Predictors of Somatoform Disorders in Patients with Suspected Allergies. Psychosom Med 
2009;71:1004-1011. 
 8.  Løvik M. Increased occurrence of allergy - is modern lifestyle the cause? Tidskr Nor 
Legeforen 2000;120:3287-3291. 
 9.  Mayer EA, Naliboff BD, Chang L, Coutinho S. Stress and the gastrointestinal tract: Stress 
and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280:G519-
G524. 
 10.  Kuby J, Kindt TJ, Goldsby RA, Osborne BA. Hypersensitivity Reactions. In: Kuby J, Kindt 
TJ, Goldsby RA, and Osborne BA., eds. Immunology. New York: W. H. Freeman and 
Company, 2006:371-400. 
 11.  Kuby J, Kindt TJ, Goldsby RA, Osborne BA. Tolerance and Autoimmunity. In: Kuby J, 
Kindt TJ, Goldsby RA, and Osborne BA., eds. Immunology. New York: W. H. Freeman 
and Company, 2006:401-424. 
 12.  Berman BA, Kniker WT, Cohen GA. An allergist`s view of atopic dermatitis. Dermatol 
Clin 1986;4:55-66. 
 13.  Brandtzaeg P. Mechanisms of gastrointestinal reactions to food. Pharmacol 1997;4:9. 
 14.  Johansson SG, Dannaeus A, Lilja G. The relevance of anti-food antibodies for the diagnosis 
of food allergy. Ann Allergy 1984;53:665-672. 
58
 15.  Husby S, Foged N, Host A, Svehag SE. Passage of dietary antigens into the blood of 
children with coeliac disease. Quantification and size distribution of absorbed antigens. Gut 
1987;28:1062-1072. 
 16.  Weiner HL, van Rees EP. Mucosal tolerance. Immunology Letters 1999;69:3-4. 
 17.  Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and 
clinical perspectives. Gastroenterology 2005;128:1089-1113. 
 18.  Bloomfield SF, Stanwell-Smith R, Crevel RWR, Picup J. Too clean, or not too clean: 
Hygiene Hypothesis and home hygiene. Clin Exp Allergy 2006;26:402-425. 
 19.  von Herrath M. Can We Learn From Virus How to Prevent Type 1 Diabetes? Diabetes 
20009;58:2-11. 
 20.  Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity - friends or 
foes? Trends Immunol 2009;30:409-414. 
 21.  Bennet R, Eriksson M, Tafari N, Nord KE. Intestinal bacterial of newborn Ethiopian infants 
in relation to antibiotic treatment and colonisation by potentially pathogenic bacteria. Scan J 
Infect Dis 1991;23:63-69. 
 22.  Bjorksten B. Genetic and environmental risk factors for the development of food allergy. 
Curr Opin Allergy Clin Immunol 2005;5:249-253. 
 23.  Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian 
and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342-346. 
 24.  Bjorksten B. The hygiene hypothesis: do we still believe in it? Nestle Nutr Workshop Ser 
Pediatr Program 2009;64:11-18. 
 25.  Celedon AC, Fuhlbrigge A, Rifas-shima S, Weiss ST, Finkelstein A. Antibiotic use in the 
first year of life and asthma in early childhood. Clin Exp Allergy 2004;34:1011-1016. 
 26.  Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega 
Martell JA, Platts-Mills TA, Ring J, Thien F, van Cauwenberge P, Williams HC. Revised 
nomenclature for allergy for global use: Report of the Nomenclature Review Committee of 
the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-836. 
 27.  Nowak-Wegrzyn A. Food-allergic reactions in schools and preschools. Arch Pediatr 
Adolesc Med 2001;155:790-795. 
 28.  Jansen JJ, Kardinaal AF, Huijbers G, Vlieg-Boerstra BJ, Martens BP, Ockhuizen T. 
Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin 
Immunol 1994;93:446-456. 
 29.  Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F. 
Population study of food allergy in France. J Allergy Clin Immunol 2001;108:133-140. 
 30.  Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food 
intolerance. Lancet 1994;343:1127-1130. 
59
 31.  Sampson HA. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J Allergy 
Clin Immunol 1999;103:717-728. 
 32.  Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004;113:805-819. 
 33.  Hill DJ, Hosking CS, Heine RG. Clinical spectrum of food allergy in children in Australia 
and South-East Asia: identifications and targets for treatment. Ann Med 1999;31:272-281. 
 34.  Chung SY, Butts CL, Maleki SJ, Champagne E. Linking peanut allergenicity to the 
processes of maturation, curing and roasting. J Agric Food Chem 2003;51:4273-4277. 
 35.  Dalal I, Binson I, Reifen R, Amitai Z, Shohat T, Rahamani S, Levine A, Ballin A, Somekh 
E. Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-
mediated food allergic reactions among infants and young children in Israel. Allergy 
2002;57:362-365. 
 36.  Anibarro B, Seoane FJ, Mugica MV. Involvment of Hidden Allergens in Food Allergic 
Reactions. J Investig Allergol Clin Immunol 2007;17:168-172. 
 37.  Jenkins JA, Breitender H, Clare Mills EN. Evolutionary distance from human homologs 
reflects allergenicity of animal food proteins. J Allergy Clin Immunol 2007;120:1399-1405. 
 38.  Commins SP, Platts-Mills TAE. Anaphylaxis syndromes related to a new mammalian cross-
reactive carbohydrate determinant. J Allergy Clin Immunol 2009;124:652-657. 
 39.  Cianferoni A, Spergel JM. Food Allergy: Review, Classification and Diagnosis. Allergol Int 
2009;58:457-466. 
 40.  Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, Blanco C, Ebner C, Hourihane J, 
Knulst AC, Moneret-Vautrin DA, Nekam K, Niggemann B, Osterballe M, Ortolani C, Ring 
J, Schnopp C, Werfel T. Standardization of food challenges in patients with immediate 
reactions to foods - position paper from the European Academy of Allergology and Clinical 
Immunology. Allergy 2004;59:690-697. 
 41.  Bischoff SC, Grabowsky J, Manns MP. Quantification of inflammmatory mediators in stool 
samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 
1997;42:394-403. 
 42.  Bischoff SC, Mayer J, Wedemeyer J, Meier PN, Zeck-Kapp G, Wedi B, Kapp A, Cetin Y, 
Gebel M, Manns MP. Colonoscopic allergen provocation (COLAP): A new diagnostic 
approach for gastrointestinal food allergy. Gut 1997;40:745-753. 
 43.  Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Immunohistological assessment 
of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and 
inflammatory bowel disease. Am J Gastroenterol 1999;94:3521-3529. 
 44.  Kosa L, Kereki E, Borzsonyl L. Copro-eosinophil cationic protein (ECP) in food allergy. 
Allergy 1996;51:964-966. 
 45.  Santos J, Saperas E, Nogueiras C, Mourelle M, Antolin M, Cadahia A, Malagelada JR. 
Release of mast cell mediators into the jejunum by cold pain stress in humans. 
Gastroenterology 1998;114:640-648. 
60
 46.  Santos J, Bayarri C, Saperas E, Nogueiras C, Antolin M, Mourelle M, Cadahia A, 
Malagelada JR. Characterisation of immune mediator release during the immediate response 
to segmental mucosal challenge in the jejunum of patients with food allergy. Gut 
1999;45:553-558. 
 47.  Arslan G, Gilja OH, Lind R, Florvaag E, Berstad A. Response to intestinal provocation 
monitored by transabdominal ultrasound in patients with food hypersensitivity. Scan J 
Gastroenterol 2005;40:386-394. 
 48.  Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic 
reactions to food, 2001-2006. J Allergy Clin Immunol 2007;119:1016-1018. 
 49.  Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, Goldfarb J, Sampson 
HA, Li XM. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic 
reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005;115:171-178. 
 50.  Jahn-Schmid B, Harwanegg C, Hiller R, Bohle B, Ebner C, Scheiner O, Mueller MW. 
Allergen microarray: comparison of microarray using recombinant allergens with 
conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin 
Exp Allergy 2003;33:1443-1449. 
 51.  Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, pattern, and impact of irritable 
bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 
2003;17:643-650. 
 52.  Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and 
functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006;18:595-607. 
 53.  Simrèn M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, 
Bjornsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. 
Digestion 2001;63:108-115. 
 54.  Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? 
Lancet 2002;360:555-564. 
 55.  Öhman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and 
neuroimmune interactions. Gastroenterol Hepatol 2010;7:163-173. 
 56.  Collins SM, Bercik P. The relationship between intestinal microbiota and the central 
nervous system in normal gastrointestinal function and disease. Gastroenterology 
2009;136:2003-2014. 
 57.  Horwitz BJ, Fisher RS. The Irritable Bowel Syndrome. N Engl J Med 2001;344:1846-1850. 
 58.  Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen 
E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs 
significantly from that of healthy subjects. Gastroenterology 2007;133:24-33. 
 59.  Spiller RC. Infection, immune function, and functional gut disorders. Clin Gastroenterol 
Hepatol 2004;2:445-455. 
61
 60.  Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. 
Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-II47. 
 61.  Drossman DA. The functional Gastrointestinal Disorders and the Rome III process. 
Gastroenterology 2006;130:1377-1390. 
 62.  Plumme JT. Lifestyle patterns and commercial bank creditcard usage. Journal of Marketing 
1971;35:35-41. 
 63.  Cocherham WC, Abel T, Lüschen G. Max Weber, formal rationality, and health lifestyles. 
Sociol Quart 1993;34:413-425. 
 64.  Blaxter M. Health and Lifestyles. London: Taylor & Francis, 2005. 
 65.  Aarø LE, Wold G, Kannas E, Rimpäla M. Health behavior in schoolchildren. A WHO 
cross-national survey. A presentation of philosophy, methods and selected results of the first 
survey. Health Promotion 1986;1:17-33. 
 66.  Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nature 
Rev Immunol 2006;6:869-874. 
 67.  Hitjazi N, Abalkail B, Seaton A. Diet and childhood asthma in a society in transition; a 
study in urban and rural Saudi Arabia. Thorax 2000;55:775-776. 
 68.  Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory disease. Am J 
Clin Nutr 2006;83:1505S-1519S. 
 69.  Prescott SL, Calder PC. N-3 polyunsaturated fatty acids and allergic disease. Curr Opin Clin 
Nutr Metab Care 2004;7:123-129. 
 70.  Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woodcook AJ. Consumption of oil 
fish and childhood asthma risk. Med J Aust 1996;164:137-140. 
 71.  Anandan C, Nurmatov U, Sheikh A. Omega 3 and 6 oils for primary prevention of allergic 
disease: systematic review and meta-analysis. Allergy 2009;64:840-848. 
 72.  Quigley EM. Probiotics and irritable bowel syndrome: a rationale for the use and 
assessment of the evidence to date. Neurogastroenterol Motil 2007;19:166-172. 
 73.  Jonkers D, Stockbrûgger R. Review article: probiotics in gastrointestinal and liver diseases. 
Aliment Pharmacol Ther 2007;Suppl 2:133-148. 
 74.  Morcos A, Dinan T, Quigley EMM. Irritable bowel syndrome: Role of food in pathogenesis 
and management. Journal of Digestive Diseases 2009;10:237-246. 
 75.  Valeur J, Morken MH, Norin E, Midtvedt T, Berstad A. Carbohydrate intolerance in 
patients with self-reported food hypersensitivity: Comparison of lactulose and glucose. Scan 
J Gastroenterol 2009;44:1416-1423. 
 76.  Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy jr 
WS, Drossman DA. A Very Low-Carbohydrate Diet Improves Symptoms and Quality of 
62
Life in Diarrhoea-Predominant Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 
2009;7:706-708. 
 77.  Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal 
symptoms: The FODMAP approach. Gastroenterol Hepatol 2009;25:252-258. 
 78.  Ford AC, Talley NJ, Spiegel BM. Effect of fibre, antispasmodics, and peppermint oil in the 
treatment of irritable bowel syndrome: systematic review and meta-analysis. Br Med J 
2008;337:a2313. 
 79.  Dapoigny M, Stockbrugger RW, Azpiroz F, Collins S, Coremans G, Muller-Lissner S, 
Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P. Role of alimentation in irritable 
bowel syndrome. Digestion 2003;67:225-233. 
 80.  Heizer WD, Southern S, McGovern S. The Role of Diet in Symptoms of Irritable Bowel 
Syndrome in Adults: A Narrative Review. J Am Diet Assoc 2009;109:1204-1214. 
 81.  Derek G, Johnston R, Pratt G, et al. Quality of Life. Oxford: Wiley-Blackwell, 2009. 
 82.  The WHOQOL Group. The Development of the World Health Organization Quality of Life 
Assessment Instrument (the WHOQOL). In: Orley J and Kuyken W., eds. Quality of Life 
Assessment: International Perspectives. Berlin: Springer-Verlag, 1994:41-45. 
 83.  Cella DF, Bonomi AE. Measuring quality of life today: 1995 update. Oncology 1995;9:47-
60. 
 84.  Chang L. Review article: epidemiology and quality of life in functional gastrointestinal 
disorders. Aliment Pharmacol Ther 2004;20 (Suppl. 7):31-39. 
 85.  Lea R, Whorwell PJ. Quality of Life in Irritable Bowel Syndrome. Pharmaco Economics 
2001;19:643-653. 
 86.  Naliboff BD, Balice G, Mayer EA. Psychosocial moderators of quality of life in irritable 
syndrome. Eur J Surg Suppl 1998;57-59. 
 87.  Palsson OS, Jones KR, Turner MJ, Drossman DA, Whitehead WE. Impact of somatization 
and comorbid medical conditions on health care utilization, disability, and quality of life in 
irritable bowel syndrome (IBS). Gastroenterology 2002;122 (Suppl 1):A501-502. 
 88.  El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with 
irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-
1185. 
 89.  Eriksen HR, Ihlebaek C, Ursin H. A scoring system for subjective health complaints (SHC). 
Scan J Public Health 1999;1:63-72. 
 90.  Reid S, Wessley S, Crayford T, Hotopf M. Medically unexplained symptoms in frequent 
attenders of secondary health care: retrospective cohort study. BMJ 2001;322:770. 
 91.  Eriksen HR, Ihlebaek C. Subjective health complaints. Scan J Psychol 2002;43:101-103. 
63
 92.  Eriksen HR, Ursin H. Subjective health complaints: Is coping more important than control? 
Work Stress 1999;13:238-252. 
 93.  Guze SB. The validity and significance of the clinical diagnosis of hysteria (Briquet`s 
syndrome). Am J Psychiatry 1975;132:138-141. 
 94.  Eriksen HR, Ursin H. Sensitization and subjective health complaints. Scand J Psychol 
2002;43:189-196. 
 95.  Eriksen HR, Svendsroed R, Ursin G, Ursin H. Prevalence of subjective health complaints in 
the Nordic European countries in 1993. Eur J Public Health 1998;8:294-298. 
 96.  Tveito TH, Halvorsen A, Lauvålien JV, Eriksen HR. Room for everyone in the working 
life? 10% of the employees - 82% of the sickness leave. Norsk Epidemiologi 2002;12:63-
68. 
 97.  Eriksen HR, Ursin H. Subjective health complaints, sensitization, and cognitive activation 
(stress). J Psychosom Res 2004;54:445-448. 
 98.  van den Bergh O, Winters W, Devriese S, van Diest I. Learning subjective health 
complaints. Scan J Psychol 2002;43:147-152. 
 99.  Brosschot JF. Cognitive-emotional sensitization and somatic health complaints. Scand J 
Psychol 2002;43:113-121. 
 100.  Overmier J. Sensitization, conditioning, and learning: Can they help us understand 
somatisation and disability? Scan J Psychol 2002;43:105-112. 
 101.  Wilhelmsen I. Somatization, sensitization, and functional dyspepsia. Scand J Psychol 
2002;43:177-180. 
 102.  Bailey PE, Henry JD. Alexithymia, somatization and negative affect in a community 
sample. Psychiatry Res 2007;150:13-20. 
 103.  Duddu V, Isaac MK, Chaturvedi SK. Alexithymia in somatoform and depressive disorders. 
J Psychosom Res 2003;54:435-438. 
 104.  Ursin H. Sensitization, somatization and subjective health complaints. J Behav Medicine 
1997;4:105-116. 
 105.  Levine S, Ursin H. What is stress? In: Brown MR, Rivier C, and Koob G., eds. Stress, 
Neurobiology and Neuroendocrinology. New York: Marcel Decker: 1991: pp 3-21. 
 106.  Ursin H, Eriksen HR. The Cognitive Activation Theory of Stress. 
Psychoneuroendocrinology 2004;29:567-592. 
 107.  Ursin H. The development of a Cognitive Activation Theory of Stress: From limbic 
structures to behavioral medicine. Scan J Psychol 2009;50:639-644. 
 108.  Karasek R, Theorell T. Healthy work: Stress, productivity, and the reconstruction of 
working life. New York: Basic Books, Inc. Publishers, 1990. 
64
 109.  Johnson ME, Brems C, Mills ME, Neal DB, Houlihan JL. Moderating Effects of Control on 
the Relationship between Stress and Change. Adm Policy Ment Health Serv Res 
2006;33:499-503. 
 110.  Karasek RA. Job Demands, Job Decision Latitude, and Mental Strain: Implications for Job 
Redesign. Admin Sci Q 1979;24:285-308. 
 111.  Tachè Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-
related alterations of gut motor function: role of brain corticotropin-releasing factor 
receptors. Am J Physiol Gastrointest Liver Physiol 2001;280:G173-G177. 
 112.  Berstad A, Arslan G, Lind R, Florvaag E. Food hypersensitivity-immunologic (peripheral) 
or cognitive (central) sensitisation? Psychoneuroendocrinology 2005;30:983-989. 
 113.  Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IM. Corticotropin-
releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J 
Clin Endocrinol Metab 2003;88:5427-5432. 
 114.  Alonso C, Guilarte M, Vicario M, Ramos L, Ramdan Z, Antolin M, Martinez C, Rezzi S, 
Saperas E, Kochhar SJ, Malgelada JR. Maladaptive Intestinal Epithelial Responses to Life 
Stress May Predispose Healthy Women to Gut Mucosal Inflammation. Gastroenterology 
2008;135:163-172. 
 115.  Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York: Springer, 1984. 
 116.  Billings AG, Moos RH. The role of coping responses and social resources in attenuating the 
stress of life events. J Behav Medicine 1981;4:139-157. 
 117.  Usrin H, Endresen IM, Ursin G. Psychological factors and self-reports of muscle pain. Eur J 
Appl Physiol 1988;57:283-290. 
 118.  Delsignore A, Schnyder U. Control expectancies as predictors of psychotherapy outcome: A 
systematic review. Br J Clin Psychol 2007;46:467-483. 
 119.  Arnkoff DB, Glass CR, Shapiro DA. Expectations and preferences. In: Norcross JC., ed. 
Psychotherapy relationships that work. Oxford: University press: 2002:335-356. 
 120.  Rotter JB. Generalized expectancies for internal versus external control of reinforcement. 
Psychological Monographs 1996;80(1):Whole No. 609. 
 121.  Petrie KJ. Modern worries, new technology, and medicine. BMJ 2002;324:690-691. 
 122.  Petrie KJ, Sivertsen B, Hysing M, Broadbent E, Moss-Morris R, Eriksen HR, Ursin H. 
Thoroughly modern worries - The relationship of worries about modernity to report 
symptoms, health and medical care utilization. J Psychosom Res 2001;51:395-401. 
 123.  Devcich DA, Pedersen IK, Petrie KJ. You eat what you are: Modern health worries and the 
acceptance of natural and syntetic additives in functional foods. Appetite 2007;48:333-337. 
 124.  Reading A. Illness and disease. Med Clin North Am 1977;61:703-706. 
65
 125.  Drossman DA. Presidential Address: Gastrointestinal Illness and the Biopsychosocial 
Model. Psychosom Med 1998;60:258-267. 
 126.  Engel GL. The need for a new medical model: A challenge for biomedicine. Science 
1977;196:129-136. 
 127.  Tavakoli HR. A Closer Evaluation of Current Methods in Psychiatric Assessments. A 
Challenge for the Biopsychosocial Model. Psychiatry 2009;6:25-30. 
 128.  McLaren NA. A critical review of the biopsychosocial model. J Psychiatry 1998;32:86-92. 
 129.  Gaman A, Kuo B. Neuromodulatory processes of the brain-gut axis. Neuromodulation 
2009;11:249-259. 
 130.  Zachariae R. Psychoneuroimmunology: A bio-psycho-social approach to health and disease. 
Scan J Psychol 2009;50:645-651. 
 131.  Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain 
Behav Immun 2010;24:9-16. 
 132.  Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation 
of inflammatory disease. Ann Intern Med 1992;117:854-866. 
 133.  World Medical Association Inc. Declaration of Helsinki. Ethical principles for medical 
research involving human subjects. J Indian Med Assoc 2009;107:403-405. 
 134.  Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of 
the Nepean Dyspepsia Index and development of a new 10-items short form. Aliment 
Pharmacol Ther 2001;15:207-216. 
 135.  Svedlund J, Sjödin I, Dotevall G. GSRS-A Clinical Rating Scale for Gastrointestinal 
Symptoms in Patients with Irritable Bowel syndrome and Peptic Ulcer Disease. Dig Dis Sci 
1988;33:129-134. 
 136.  Olafsson S, Berstad A. Changes in food intolerance and lifestyle after eradication of 
helicobacter pylori. Scan J Gastroenterol 2003;3:268-276. 
 137.  Dimenäs E, Glise H, Hallerbäck B, Hernquist H, Svedlund J, Wiklund I. Quality of life in 
patients with upper gastrointestinal symptoms. An improved evaluation of treatments 
regimens? J Gastroenterol 1993;28:681-687. 
 138.  Olafsson S, Hatlebakk JG, Berstad A. Patients with endoscopic gastritis and/or duodenitis 
improve markedly following eradication of Helicobacter pylori, although less so than 
patients with ulcers. Scand J Gastroenterol 2002;37:1386-1394. 
 139.  Mills PK, Beeson WL, Phillips RL. "Cohort study of diet, lifestyle, and prostate cancer in 
Adventist men". Cancer 1989;64:598-604. 
 140.  Johannessen T, Petersen H, Kleveland PM, Dybdahl JH, Sandvik AK, Brenna E, Waldum 
H. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990;25:689-697. 
 141.  Cooper CL. The stress check. New York: Precentice Hall, 1981. 
66
 142.  Theorell T, Perski A, Akerstedt T, Sigala F, Albergh-Hulten G, Svensson J, Eneroth P. 
Changes in job strain in relation to changes in physiological state. Scand J Work Environ 
Health 1988;14:189-196. 
 143.  Schreurs PJG, van De willige G, Brosscot JF, Grau G. De Utrechtse Copinglijst: UCL. 
Handleiding. (2 Rev ed.). Lisse: Swets en Zeitlinger, 1993. 
 144.  Stubhaug B, Tveito TH, Eriksen HR, Ursin H. Neurasthenia, subjective health complaints 
and sensitization. Pseudoneuroendocrinology 2005;30:1003-1009. 
 145.  Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, Naliboff BD. The Visceral 
Sensitivity Index: development and validation of a symptom-specific anxiety scale. Aliment 
Pharmacol Ther 2004;20:89-97. 
 146.  Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The Central Role of Gastrointestinal-
Specific Anxiety in Irritable Bowel Syndrome: Further Validation of Visceral Sensitivity 
Index. Psychosom Med 2007;69:89-98. 
 147.  Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a 
review of validation data and clinical results. J Psychosom Res 1997;42:17-41. 
 148.  Mykletun A, Stordal E, Dahl AA. The Hospital Anxiety and Depression Scale (HADS): 
Factor structure, item analysis, and internal consistency in a large population. Br J 
Psychiatry 2001;179:540-544. 
 149.  Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyery D, Camilleri M, Hanauer B. 
Fecal Lactoferrin is a Sensitive and Specific Marker in Identifying Intestinal Inflammation. 
Am J Gastroenterol 2003;98:1309-1314. 
 150.  Bland JM, Altman DG. Statistical methods for assessing agreement between two methods 
of clinical measurement. Lancet 1986;8:307-310. 
 151.  Bland JM, Altman DG. Validating scales and indexes. Br Med J 2002;324:606-607. 
 152.  Chronbach IJ, Shavelson RJ. My Current Thoughts on Coefficient Alpha and Successor 
Procedures. Educ Psychol Meas 2004;64:391-418. 
 153.  Normann GR, Stratford P, Regehr G. Methodological problems in the retrospective 
computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol 
1997;50:869-879. 
 154.  Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a 
critical reviw and recommendations. J Clin Epidemiol 2000;53:459-468. 
 155.  Pearson DJ, Rix KJ, Bentley SJ. Food allergy: How much in the mind? Lancet 
1983;6:1259-1261. 
 156.  Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment 
Pharmacol Ther 2001;15:439-449. 
67
 157.  Lind R, Lied GA, Lillestøl K, Valeur J, Berstad A. Do psychological factors predict 
symptom severity in patients with subjective food hypersensitivity? Scan J Gastroenterol 
2010;In press: (DOI: 10.3109/00365521003797213). 
 158.  Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life 
associated with irritable bowel syndrome: Comparison with other chronic diseases. Clin 
Ther 2002;24:675-689. 
 159.  Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel 
syndrome on health-related quality of life. Gastroenterology 2000;119:655-660. 
 160.  Spiegel BMR, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, Naliboff B. Clinical 
determinants of health-related quality of life in irritable bowel syndrome. Arch Intern Med 
2004;164:1773-1780. 
 161.  Donker GA, Foets M, Streeuwenberg P. Patients with irritable bowel syndrome: Health 
status and use of health care services. British J Gen Practice 1999;49:787-792. 
 162.  Li FX, pattern SB, Hilsden RJ, Sutherland LR. Irritable bowel syndrome and health-related 
quality of life: a population-based study in Calgary, Alberta. Can J Gastroenterology 
2003;17:259-263. 
 163.  Lillestøl K, Berstad A, Lind R, Florvaag E, Arslan Lied G, Tangen T. Anxiety and 
depression in patients with self-reported food hypersensitivity. Gen Hosp Psychiatry 
2009;32:42-48. 
 164.  Teufel M, Biedermann T, Rapps N, Hausteiner C, Henningsen P, Enck P, Zipfel S. 
Psychological burden of food allergy. World J Gastroenterol 2007;13:3456-3465. 
 165.  Berstad A, Arslan G, Lind R, Florvaag E. Food hypersensitivity - immunologic (peripheral) 
or cognitive (central) sensitisation? Psychoneuroendocrinology 2005;30:983-989. 
 166.  Riedl A, Maass J, Fliege H, Stengel A, Schmidtmann M, Klapp BF, Mönnikes H. 
Subjective theories of illness and psychological outcomes in patients with irritable bowel 
syndrome. J Psychosom Res 2009;67:449-455. 
 167.  Drossmann DA, Whitehead WE, Toner BB, Diamant D, Hu Y, Bangdiwala SI, Jia H. What 
determines severity among patients with painful functional bowel disorders? Am J 
Gastroenterol 2000;95:974-980. 
 168.  Chang FY, Lu CL. Treatment of Irritable Bowel Syndrome Using Complementary and 
Alternative Medicine. Chin med Assoc 2009;72:294-300. 
 169.  Johansson PA, Farup PG, Bracco A, Vandvik PO. How does comorbidity affect cost of 
health care in patients with irritable bowel syndrome? A cohort study in general practice. 
BMC Gastroenterology 2010;10:31-36. 
 170.  Dalton CB, Drossman DA, Hathaway MD, Bangdiwala SI. Perceptions of physicians and 
patients with organic and functional gastroenterological diagnoses. J Clin Gastroenterol 
Hepatol 2004;2:121-126. 
68
 171.  Heitkemper M, Carter E AV, Olden K, Cheng L. Women with irritable bowel syndrome: 
differences in patients` and physicians` perceptions. Gastroenterol Nurs 2002;25:192-200. 
 172.  Drossman DA. The "organification" of functional GI disorders: implications for research. 
Gastroenterology 2003;124:6-7. 
 173.  Longstreth GF, Drossman DA. Severe irritable bowel and functional abdominal pain 
syndromes: managing the patient and health care costs. Clin Gastroenterol Hepatol 
2005;3:397-400. 
 174.  Dalèn P. Somatic medicine abuses psychiatry - and neglect causal research. http:/art-
bincom/art/dalen_en htlm, downloaded 07-08- 2010. 
 175.  Fava GA, Sonino N. The Biopsychosocial Model Thirty Years Later. Psychother 
Psychosom 2008;77:2. 
 176.  Filipkowski K, Smyth JM, Rutchick AM, Santuzzi AM, Adya M, Petrie K, Kaptein AA. Do 
Healty People Worry? Modern Health Worries, Subjective Health Complaints, and Health 
Care Utilization. Int J Behav Med 2009;In press: (DOI:10.1007/s12529-009-9058-0). 
 177.  Furnham A. Are modern health worries, personality and attitudes to science associated with 
the use of complementary and alternative medicine? Br J Health Psychol 2007;12:229-243. 
 178.  Knibb RC, Booth DA, Armstrong A, Boothm IW, MacDonald A. Concequences of 
perceived food intolerance for welfare, lifestyle and food choice practies, in a community 
sample. Psychol Health Med 2000;5:419-430. 
 179.  Peveler R, Mayou R, Young E, Stoneham M. Psychiatric aspects of food-related physical 
symptoms: a community study. J Psychosom Res 1996;41:149-159. 
 180.  Jarret M, Visser R, Heitkemper M. Diet triggers symptoms in women with irritable bowel 
syndrome. Gastroenterol Nursing 2001;24:246-252. 
 181.  Jarret M, Heitkemper M, Bond EF, Georges J. Comparison of diet composition in women 
with and without functional bowel disorders. Gastroenterology Nursing 1994;16:253-258. 
 182.  Nasjonalt råd for ernæring. Nye kostråd – utkast til rapport lagt frem. Helse-og 
omsorgsdepartementet, Oslo, Norge 2010. 
 183.  Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, Sigurdardottir ST, 
Lindner T, Goldhahn K, Dahlstrom J, McBride D, Madsen C. The prevalence of food 
allergy: A meta-analysis. J Allergy Clin Immunol 2007;120:638-646. 
 184.  Jones MP, Wessinger S, Crowell MD. Coping strategies and interpersonal support in 
patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol 
Hepatol 2006;4:474-481. 
 185.  Lind R, Lillestøl K, Valeur J, Eriksen HR, Tangen T, Berstad A, Arslan Lied G. Job stress 
and coping strategies in patients with subjective food hypersensitivity. Scand J Psychol 
2010;51:179-184. 
69
 186.  Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in 
Irritable Bowel Syndrome. Am J Gastroenterol 2007;102:2767-2776. 
 187.  Petrie KJ, Broadbent E. Assessing illness behaviour: What condition is my condition in? J 
Psychosom Res 2005;54:415-416. 
 188.  Eriksen HR., Ursin H. Social inegualities in health: Biological, cognitive and learning 
theory perspectives. Norsk Epidemiologi 2002;1:33-38. 
 189.  Eriksen RH, Usrin H. Stress and coping: does it matter? Doctoral Thesis, University of 
Bergen, Norway 1998;5th Article. 
 190.  Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans LM, Simrén M. 
Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and 
quality of life in IBS. Neurogastroenterol Motil 2010;(In press: DOI:10.1111/j.1365-
2982.2010.01493). 
 191.  Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, Burger 
AL. Psychological factors in irritable bowel syndrome. A multivariate study of patients and 
nonpateints with irritable bowel syndrome. Gastroenterology 1988;95:701-708. 
 192.  Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in 
the community: is there a link? Am J Gastroenterol 2001;96:943-945. 
 193.  Suerbaum S, Michetti P. Helicobacter pylori Infection. NEJM 2002;347:1175-1186. 
 194.  Wilhelmsen I, Berstad A. Reduced relapse rate in duodenal ulcer disease leads to 
normalization of psychological distress: twelve-year follow-up. Scand J Gastroenterol 
2004;39:717-721. 
 195.  Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for 
inflammation in irritable bowel syndrome? Gut 2002;51 Suppl 1:i41-i44. 
 196.  Gwee KA, Leong YL, Graham C, Collins SM, Walters SJ, Underwood JE, Read NW. The 
role of psychological and biological factors in postinfective gut dysfunction. Gut 
1999;44:400-406. 
 197.  Treem WR, Ashan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with 
diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate 
fermentation. J Pediatr Gastroenterol Nutr 1996;23:280-286. 
 198.  Lillestøl K, Helgeland L, Lied GA, Florvaag E, Valeur J, Lind R, Berstad A. Indications of 
"atopic bowel" in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther 
2010;Accepted for publication. 
 199.  Gregersen K, Lind R, Valeur J, Bjørkkjær T, Berstad A, Lied GA. Duodenal administered 
seal oil for patients with subjective food hypersensitivity: An explorative open pilot study. 
Int J Gen Med 2010;(Accepted July 2010). 
 200.  Bjoerkkjaer T, Brunborg LA, Arslan G, Lind R, Brun JG, Valen M, Klementsen B, Berstad 
A, Frøyland L. Reduced Joint Pain after Short-term Duodenal Administration of Seal Oil in 
70
Patients with Inflammattory Bowel Disease: Comparison with Soy Oil and Seal Oil. Scan J 
Gastroenterol 2004;11:1088-1094. 
 201.  Lied GA, Lillestøl K, Valeur J, Berstad A. Intestinal B cell-activating factor: an indicator of 
non-IgE-mediated hypersensitivity reactions to food? Aliment Pharmacol Ther 
2010;Accepted for publication. 
 202.  Morken Hetlevik M, Berstad Elnaes A, Nysaeter G, Berstad A. Intestinal gas in plain 
abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J 
Gastroenterol Hepatol 2007;19:589-593. 
 203.  Koide A, Yamaguchi T, Odaka T, Koyama H, Tsuyuguchi T, Kitahara H, Ohto M, Saisho 
H. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with 
irritable bowel syndrome. Am J Gastroenterol 2000;95:1735-1741. 
 204.  Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of 
intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel 
syndrome. Neuroenterology Motil 2009;22:493-498. 
 205.  Morken MH, Valeur J, Norin E, Midtvedt T, Nysæter G, Berstad A. Antibiotic or bacterial 
therapy in post-giardiasis irritable bowel syndrome. Scan J Gastroenterol 2009;44:1296-
1303. 
 206.  Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in 
patients with persistent abdominal symptoms following Giardia lamblia infection. Scan J 
Gastroenterol 2008;43:141-145. 
 207.  Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet 
1994;344:39-40. 
 208.  Sheperd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in 
patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin 
Gastroenterol Hepatol 2008;6:765-771. 
71
Appendix I 
Forventninger til mat  
(Expectancies to Food, ETF) 
Nedenfor finner du eksempler på utsagn som beskriver hvilke forventninger du har til mat, for 
eksempel oppblåsthet, forstoppelse, diaré, tidlig metthet, kvalme, magesmerter, tretthet, utslett, 
muskel-/ledd smerter eller hodepine. Vennligst kryss av ett alternativ for hvert spørsmål. 
Spørsmål 
Nesten 
aldri Sjelden Ofte 
Veldig 
ofte 
1. Jeg føler meg stresset av at jeg bestandig må ta hensyn til hva jeg spiser     
2. Jeg vet ikke sikkert hvilken mat som er årsak til plagene     
3. Selv når jeg utelukker mat jeg ikke tåler, føler jeg meg ikke trygg     
4. Det plager meg veldig at reaksjonene på mat er så uforutsigbare     
5. Jeg tror at jeg selv skal klare å finne ut av plagene mine     
6. Når jeg får plager på grunn av mat, vet jeg hva jeg kan gjør for å lindre dem     
7. Når jeg utelukker mat jeg ikke tåler, føler jeg meg trygg     
8. Når jeg er i godt humør, betyr det mindre hva jeg spiser     
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APPENDIX II 
Questionnaires IBS-SQ   
SHC- 
Non-GS 
R square B P-value R square B P-value 
HADS-A, VSI, HADS-D 0.094 0.088 0.022  0.686 
HADS-A, VSI, HADS-D, AGE 0.094 0.164 0.133  0.096 
HADS-A -0.322 0.465  0.584 0.103 
VSI 0.186 0.024  -0.042 0.513 
HADS-D 0.620 0.285  -0.559 0.220 
AGE -0.015 0.850  0.155 0.012 
Visceral Sensitivity Index (VSI), Hospital Anxiety Depression Scale (HADS-A and HADS-D) 
Questionnaires IBS-SQ   
SHC- 
Non-GS 
R square B P-value R square B P-value 
HADS-A, ETF, HADS-D 0.079  0.139 0.052  0.310 
HADS-A, ETF, HADS-D, AGE 0.081  0.232 0.128  0.060 
HADS-A  0.134 0.734  0.487 0.114 
ETF  4.307 0.042  -2.032 0.210 
HADS-D  0.260 0.654  -0.441 0.326 
AGE  0.029 0.709  0.141 0.020 
Expectancies to Food (ETF), Hospital Anxiety Depression Scale (HADS-A and HADS-D) 

